СПОСОБ ПРОИЗВОДСТВА МОЛОКА ИЛИ МОЛОЧНЫХ ПРОДУКТОВ С ВЫСОКИМ СОДЕРЖАНИЕМ МЕЛАТОНИНА

Изобретение относится к области животноводства. Суточный цикл одной или более самок млекопитающих разделен на фазу дневного времени с первым световым режимом с долей синего света и фазу ночного времени со вторым световым режимом. Животных доят, по меньшей мере, один раз во время фазы ночного времени. Во время фазы ночного времени, по меньшей мере, один источник света используют для светового режима, который излучает свет в диапазоне длин волн 500 нм или более и, в основном, не излучает свет в диапазоне длин волн ниже 500 нм. Полученное молоко может быть обработано с образованием молочных продуктов, в частности сухого молока, с высоким содержанием мелатонина. Способ позволяет получить молоко и молочные продукты с высоким содержанием мелатонина, которые могут быть использованы в качестве биологически активных добавок к пище или лекарственных средств. 3 н. и 14 з.п. ф-лы, 3 ил., 2 табл.

АППАРАТ ЦВЕТОИМПУЛЬСНОЙ СТИМУЛЯЦИИ, ПРОФИЛАКТИКИ И КОРРЕКЦИИ ФУНКЦИОНАЛЬНЫХ СИСТЕМ ОРГАНИЗМА ЧЕЛОВЕКА

... 1. Аппарат цветоимпульсной стимуляции, профилактики и коррекции функциональных систем организма человека выполнен в виде светоизолированной, воздухопроницаемой мягкой маски с симметрично жестко закрепленными на электронной плате генератором импульсов, RGB-источниками светового излучения видимой части спектра света 400-700 нм и панели из светонепроницаемого материала с симметричными перфорированными светопроводящими зонами отверстий для воздействия на каждый глаз, отличающийся тем, что выполнен с возможностью генерации и воспроизведения модулирующих звуковых сигналов через встроенный динамик, содержит оптическую систему равномерного распределения и передачи светового потока на выходные отверстия маски, состоящую из двух пар зеркал (отражателей) первого и второго уровня, передающих световые импульсы от RGB-источников в отверстия. ! 2. Аппарат цветоимпульсной стимуляции по п.1, отличающийся тем, что одно перфорационное отверстие в центре выполнено диаметром 1,4-1,5 мм, и 4 и более отверстий ...

СПОСОБ КОРРЕКЦИИ ЗРИТЕЛЬНЫХ НАРУШЕНИЙ

... 1. Способ коррекции зрительных нарушений, заключающийся в импульсном цветовом попеременном воздействии на каждый из глаз пациента серией импульсов светового излучения в диапазоне видимого света, отличающийся тем, что попеременное воздействие на каждый глаз производят с разной длиной волны, причем при подаче следующей серии импульсов изменяют длину волны, соответствующую данному цветовому излучению, на длину волны, соответствующую оппонентному цвету. ! 2. Способ коррекции зрительных нарушений по п.1, отличающийся тем, что изменяют длину волны в сериях импульсов. !3. Способ коррекции зрительных нарушений по п.1, отличающийся тем, что импульсы подают в диапазоне частот от 0,06-1 Гц в одной серии до 0,2÷10 Гц в другой серии.

СПОСОБЫ И УСТРОЙСТВО ОСВЕЩЕНИЯ С ИЗБИРАТЕЛЬНО ПРИМЕНЯЕМЫМ КОМПОНЕНТОМ ОСВЕЩЕНИЯ ЛИЦА

... 1. Способ управления компонентом рабочего освещения и компонентом освещения лица по меньшей мере одного осветительного прибора, содержащий этапы, на которых:контролируют уровень освещенности вблизи рабочей области;обеспечивают рабочее освещение для упомянутой рабочей области по меньшей мере от одного осветительного прибора над упомянутой рабочей областью на основе упомянутого уровня освещенности вблизи упомянутой рабочей области;контролируют каждый из множества пользовательских сегментов на присутствие человека, причем упомянутые пользовательские сегменты прилегают к упомянутой рабочей области и используются для взаимодействия пользователя с упомянутой рабочей областью; иобеспечивают освещение лица от упомянутого по меньшей мере одного осветительного прибора над упомянутой рабочей областью только для данного пользовательского сегмента из упомянутых пользовательских сегментов на основе упомянутого данного пользовательского сегмента, имеющего упомянутое присутствие человека;причем одна или ...

Sauna heating device has steam unit for use as dry or wet bathing form combined with light or colored light for color therapy, and sauna ovens, on whose outer casing additional device of illumination body is equipped

The sauna heating device has steam unit for use as dry or wet bathing form combined with light or colored light for color therapy, and sauna ovens, on whose outer casing (1) an additional device of an illumination body is equipped. A light casing (5) with a color field light chamber (16) and a luminous element are mounted on one or more sides at the outer casing of the sauna oven. The light casing is formed of glass or metal with punching or recess as decoration. The illumination body is attached in a railing with oven safety guard.

Vorrichtung zum Stimulieren des Gehirns einer Person

Vorrichtung zum Stimulieren des Gehirns (3B) einer Person (2), Folgendes umfassend: (a) einen Detektor (10) zum Erfassen eines induzierten oder eines vom Gehirn (3B) erzeugten spontanen physiologischen Signals; (b) eine Steuereinheit (12), die an den Detektor (10) angeschlossen ist, um das erfasste physiologische Signal mit einem Kriterium zu vergleichen, um eine optimale Einstellung eines variablen Signalparameters zu bestimmen; (c) einen Signalgeber (8) zum Anlegen eines elektrischen Stimulationssignals (ESS) an die Person (2), wobei mindestens ein Signalparameter des Stimulationssignals (ESS) durch schrittweises Annähern auf einen Optimalwert ermittelt und in einem für die Person angelegten Speicher oder Speicherbereich abgelegt wird.

Verfahren zur Einstellung eines Lichtprofils und ein Beleuchtungssystem zur Durchführung des Verfahrens

Die Erfindung betrifft ein Verfahren zur Einstellung eines Lichtprofils in einem Beleuchtungssystem, umfassend die Schritte: Bereitstellen eines Tagesverlaufs eines helligkeitsrelevanten Beleuchtungsparameters ϕ(t) und eines spektrumrelevanten Beleuchtungsparameters λ(t) für einen vorbestimmten Tag (d_b); Bereitstellen einer Mehrzahl von Basiszeiten (t_rise_j, t_set_j, t_off_j), einer Mehrzahl von Basiswerten (ϕ_max_j, ϕ_night_j, ϕ_work_j des helligkeitsrelevanten Beleuchtungsparameters und einer Mehrzahl von Basiswerten (λ_max_j, λ_night_j, λ_work_j) des spektrumrelevanten Beleuchtungsparameters, jeweils für eine Mehrzahl von über ein Jahr verteilten Tagen (d_j), wobei zur Ermittlung des Tagesverlaufs des helligkeitsrelevanten Beleuchtungsparameters ϕ(t) und des spektrumrelevanten Beleuchtungsparameters λ(t) für einen anderen (d_j) als den vorbestimmten Tag (d_b) die jeweiligen Basiszeiten des vorbestimmten Tages (d_b) und des anderen Tages (d_j), die Basiswerte des helligkeitsrelevanten ...

Therapiegerät

Therapiegerät zur Verbesserung des physischen und des psychischen Wohlbefindens von Mensch und Tier mit mindestens einer Lichtquelle, dadurch gekennzeichnet, dass die Lichtquelle (8) aus einer Vielzahl von LEDs besteht, die in einer Packungsdichte von mehr als 4 LEDs pro cm2 angeordnet sind.

Arrangement used as a transparent shower separating wall comprises a surface coated with titanium dioxide

Arrangement comprises a surface coated with titanium dioxide. Light having a strength of at least 1000 Lux in a spectrum of 280-780 nm with a UV amount of approximately 5-7 % of the total light amount is directed onto the surface. The radiation density of the UV amount in the surface of the coating is 0.1-10 w/m2>.

Gerät für die Farblicht-Therapie

VERFAHREN ZUM BETREIBEN EINER LICHTEMITTIERENDEN BAUGRUPPE UND LICHTEMITTIERENDE BAUGRUPPE

In verschiedenen Ausführungsbeispielen wird ein Verfahren zum Betreiben einer lichtemittierenden Baugruppe (40) bereitgestellt. Bei dem Verfahren wird in einem ersten Betriebszustand erstes Licht erzeugt, das eine vorgegebene Farbtemperatur und ein vorgegebenen erstes Wellenlängenspektrum (26) hat, das so gewählt ist, dass bei einer Person, die das erste Licht wahrnimmt, eine Melatoninproduktion unterdrückt wird. In einem zweiten Betriebszustand wird zweites Licht erzeugt, das die gleiche vorgegebene Farbtemperatur und ein vorgegebenes zweites Wellenlängenspektrum (28) hat, wobei das zweite Wellenlängenspektrum (28) so gewählt wird, dass die Melatoninproduktion bei der Person, die das zweite Licht wahrnimmt, nicht unterdrückt wird.

APPARAT ZUR BEHANDLUNG VON SYMPTOMEN UNTER VERWENDUNG VON GETÖNTEM LICHT

Vorrichtung zur Kuhlenbildung in einem rieselfähigen Material

Therapeutic operative lamp for e.g. anti-rheumatic therapy, has glass jacket filled with electrically excitable inert gas, where light is irradiated through jacket over sunlight spectrum and glass of jacket is in depletion of mineral salt

The lamp has a glass jacket through which light is irradiated. The light is irradiated over a sunlight spectrum and the glass jacket is filled with an electrically excitable inert gas. The glass of the jacket is in depletion of mineral salt. The electrically excitable inert gas is provided with an additional double bond extended molecular chains. The gas exhibit radiation in vitamin-D forming spectral region. An independent claim is also included for an application of the operative lamp in e.g. work area, for providing e.g. anti-rheumatic therapy.

Vorrichtung zur Bestrahlung des menschlichen Körpers

Method and device for deep brain stimulation

Therapeutic apparatus

... 741,651. Radiation treatment. DE LA WARR, G. W. Feb. 1 1951 [Nov. 2, 1949], No. 28088/49. Class 81(2). Therapeutic apparatus comprises means for producing a beam of energy e.g. light, in the path of which is located an initiator, comprising a bar magnet or a conically wound electrically conductive spiral energised by air electrical supply, and modifying means comprising one or more resonators or a bar magnet rotatably located within and coaxial with a spiral or at least one colour filter, In one form of the invention a casing is divided into two compartments 1, 2. In one compartment 1, which is light-tight, is located an electric lamp 3 having a reflector 4 and in front of which is a lens 5 by means of which a parallel beam of light is directed towards a focussing lens 8 in the second compartment 2. The beam passes from the focussing lens 8 on to two inclined mirrors 9, 10 and thence through an aperture 11 in the front of the casing. In passing through the second compartment 2, the light ...

Portable light for adjusting circadisn rhythm

A portable optical therapeutic device which emits adequate but gentle light to the eyes of a patient. This device has such a surface emission type lighting unit that emits visible diffuse light which is fairly uniform in brightness and incident on the eyes of the patient with an illuminance of 2,000 luces, and it has an effective surface area of at least 15 cm , and is attached to the face of the patient near the eyes with an attaching member so that the diffuse light can be directed to the eyes. When this portable light is used, therefore, the patient can be irradiated with light of sufficiently high illuminance without feeling the glare of the light, and effective treatments can be given without restricting the daily actions of the patient largely. It is preferable to limit the average brightness and maximum brightness of the diffuse light emitted from the surface emission type lighting unit to 1,000-4,000 cd/m and 6,000 cd/m , respectively, to minimize the glare of the light. It is also ...

Auricular therapy apparatus

The apparatus comprises means for producing a beam of optical radiation over all of a patient's prima and modulation means to modulate the radiation. The apparatus may comprise a pair of earpieces 10 joined by a band 12 to fit on a patient's head. Each earpiece 10 may be provided with an inwardly directed light source 14 comprising a plurality of light emitting diodes (LEDs) which may be battery powered or powered from an electrical mains supply by way of a combined plug and transformer 16, a cable 18 and a control box 20. The control box 20 may comprises a switch 22 whereby the dc power to the light sources 14 is turned on to irradiate the patient's outer ears with radiation of a selected wavelength and may comprise a rotary control 24 for adjusting the length of time it is on.

Therapeutic eye-wear

... 1,142,139. Goggles. L.C.TOHA. March 28,1966 [March 29, 1965], No. 13587/66. Heading G2J. Since solar radiation passed through an interference filter transmitting a narrow band of wavelengths in the region 340-800 mÁ acts therapeutically on the retinal pigment, the, or each, lens of an eye-glass or spectacles is divided horizontally into an upper portion consisting of such a filter and a lower portion permitting normal vision.

Photic stimulation for eyes

A luminaire and illumination system

Bovine headpiece and method

Veterinary lighting apparatus

A veterinary lighting apparatus (1, fig 6) comprising a heat sink 3 on which are supported a plurality of LEDs 5 for emitting light radiation. The plurality of LEDs comprises at least one white light LED-emitter 5a, at least one blue light LED-emitter 5c and at least one red light LED-emitter 5b and an activation means to switch on one or more of the white and/or blue and/or red light LED-emitters. The lighting apparatus is preferably retrofittable to an animal housing or cage.

PORTABLE DEVICE

Goggles for eye directed light emission

Brille mit Brillenbügel (1) und ein Sichtfeld definierende Brillengläser (3), bei der erfindungsgemäß vorgeschlagen wird, dass ein Gehäuse (4) für eine Stromversorgung (5) für zumindest eine auf einem Gehäuseteil (6) angeordnete Lichtquelle (7) vorgesehen ist, wobei das Gehäuseteil (6) von einer Lagerungsposition, in der die zumindest eine Lichtquelle (7) außerhalb des Sichtfeldes angeordnet ist, in eine Gebrauchsposition, in der die zumindest eine Lichtquelle (7) innerhalb des Sichtfeldes angeordnet ist, bewegbar ist. Die Erfindung stellt somit Brillen bereit, auf denen Lichtquellen (7) mit augengerichteter Lichtemission unauffällig und mit vertretbarem Aufwand angeordnet werden können, wobei bei Nichtgebrauch der Lichtquellen (7) das Sichtfeld und somit der übliche Gebrauch der Brille nicht beeinträchtigt wird. Die erfindungsgemäße Lösung ermöglicht dabei auch einen verbesserten Schutz der Lichtquellen (7) vor mechanischen Belastungen, Spritzwasser und Verschmutzungen.

SOURCE OF LIGHT TO THE PHOTO THERAPY FOR CHRONOBIOLOGI PURPOSES

LIGHT THERAPY DEVICE

THERAPEUTIC SHOWER CUBICLE

Tragbare Vorrichtung zur Lichtemission

The invention relates to a portable apparatus for emitting light in a manner directed to the eyes, comprising at least one carrier (1) with light sources (7), a current source (3, 32) for the light sources (7) and a control unit (4) for controlling the light sources (7). According to the invention, the carrier (1) is in the form of a frame which is flexible in a U-shaped manner in the position of use, wherein at least one light source (7) or a group of light sources with light emission distributed along a section of the frame in the longitudinal direction of the frame is arranged in the central region of the frame bent in a U-shaped manner on the side of the frame directed inwards. The invention therefore provides a light-emitting apparatus which can be inconspicuously worn in the vicinity of the head with a high level of wearing comfort and, in particular, makes it possible to wear the apparatus at the same time as commercially available glasses. The handling, storage and charging of corresponding ...

Beschallungs- und Bestrahlungsvorrichtung

Vorrichtung zur Erzeugung eines Schall- oder Strahlungsfeldes zur Beschallung oder Bestrahlung einer Person, wobei ein mit einer verschließbaren Zugangsöffnung für die zu beschallende oder bestrahlende Person versehenes Gehäuse vorgesehen ist, das bei geschlossener Zugangsöffnung einen geschlossenen Innenraum bildet, dessen Innenfläche verspiegelt ausgeführt ist, und in dem Schallquellen (6) und/oder Lichtquellen angeordnet sind. Erfindungsgemäß wird vorgeschlagen, dass das Gehäuse die Form eines Kuhoktaeders (2) bildet, und im Innenraum eine Sitzgelegenheit vorgesehen ist, wobei zumindest eine Schallquelle (6) innerhalb der Sitzgelegenheit (3) mit einer in Richtung der Sitzfläche (5) gerichteten Schallemission angeordnet ist und die Sitzfläche (5) eine Schallaustrittsöffnung aufweist. Die Beschallungs- oder Bestrahlungsintensität ist aufgrund des in allen Richtungen des Beschallungs- und Bestrahlungsraumes homogenen und isotropen Schall- und Strahlungsfeldes deutlich erhöht. Mithilfe der ...

EQUIPMENT FOR BRAIN WAVE STIMULATION.

Illumination system for at least one luminous means

Es wird ein Beleuchtungssystem (1) für mindestens ein Leuchtmittel, insbesondere für Leuchtdioden, aufweisend - eine Leuchte (3) - einen Konverter (2) zum Betreiben des Leuchtmittels, - ein Erfassungsgerät (7), wobei das Erfassungsgerät (7) dazu ausgelegt ist die Schlafphase einer Person (4) festzustellen, wobei, dass das Beleuchtungssystem (1) das Leuchtmittel in unterschiedlichen Betriebsmodi betreiben kann, wobei die Betriebsmodi in Abhängigkeit von der durch das Erfassungsgerät (7) festgestellten Schlafphase der Person (4) aktiviert werden, gezeigt.

EQUIPMENT AND ACCESSORIES FOR THERAPY BY CHROMATIC SUGGESTION OF A QUARTZELEMENTES

THERAPEUTIC DEVICE FOR SENDING VISIBLE OF ELECTROMAGNETIC WAVES

Lighting devices and methods for use

An example device is configured to emit a first light having a first luminous flux and a peak intensity at a first wavelength that is greater than or equal to 400 nanometers (nm) and less than or equal to 480 urn. The first luminous flux is variable and/or the emission of the first light is interrupted one or more times. The device is also configured to emit a second, light having a second luminous flux and. a peak intensity at a second wavelength, that is greater than or equal to 500 ran and less than of equal to 630 nm. The second Luminous flux is variable and/or the emission of the second light is interrupted one or more times. The first luminous flux is at a maximum at least during a time at which the second luminous flux is not at a maximum.

Treating dementia with visual stimulation to synch gamma oscillations in brain

Devices, systems, and methods for treating dementia or Alzheimer's disease in a subject in need thereof. In one example, chronic visual stimuli having a frequency of about 30Hz to about 50 Hz, and more specifically about 40 Hz, are non-invasively delivered to the subject to entrain gamma oscillations in multiple brain regions of the subject, including the prefrontal cortex (PFC) and the hippocampus. The entrained gamma oscillations modulate neuronal activity across multiple brain regions (e.g., facilitate functional binding of neural networks at low gamma frequencies) to induce various neuroprotective effects (e.g., amelioration of amyloid plaques and tau hyper-phosphorylation) and reduce neurodegeneration. Neuronal activity mediated by the chronic visual stimuli reduces an immune response in microglia and ameliorates aberrantly modified genes and proteins involved in membrane trafficking, intracellular transport, synaptic function, neuroinflammation and DNA damage response. Behavior modification ...

Lighting systems for protecting circadian neuroendocrine function

Lighting systems, methods, and devices for protecting human circadian neuroendocrine function during night use are described. Suitable lighting conditions can be provided for a working environment while protecting the circadian neuroendocrine systems of those occupying the illuminated workplace during the night. Lighting systems, methods, and devices can provide substantive attenuation of the pathologic circadian disruption in night workers. Lighting systems, methods, and devices can attenuate the specific bands of light implicated in circadian disruption. LED lighting systems, methods, and devices can provide increased intensity at a different portion of the spectrum than conventional LEDs, providing a useable white light even when unfavorable portions of the wavelength are attenuated by a notch filter. LED lighting systems, methods, and devices can switch between a daytime configuration and a night time configuration, wherein the daytime configuration provides unfiltered light and the ...

Method of treating multiple sclerosis

A method and computer program product for suppressing the symptoms of multiple sclerosis (MS) by irradiating a subject exhibiting the symptoms with a predetermined dose of UV-containing light from a light source and detecting a suppression of the clinical symptoms of MS. In particular, the detected suppression of the clinical symptoms is disassociated from the vitamin D production within the subject.

Systems, methods and articles for enhancing wellness associated with habitable environments

Environmental characteristics of habitable environments (e.g., hotel or motel rooms, spas, resorts, cruise boat cabins, offices, hospitals and/or homes, apartments or residences) are controlled to eliminate, reduce or ameliorate adverse or harmful aspects and introduce, increase or enhance beneficial aspects in order to improve a "wellness" or sense of "wellbeing" provided via the environments. Control of intensity and wavelength distribution of passive and active Illumination addresses various issues, symptoms or syndromes, for instance to maintain a circadian rhythm or cycle, adjust for "jet lag" or season affective disorder, etc.. Air quality and attributes are controlled. Scent(s) may be dispersed. Hypoallergenic items (e.g. bedding, linens) may be used. Water quality is controlled. Noise is reduced and sounds (e.g., masking, music, natural) may be provided. Passive and active pathogen controls are employed. Controls are provided for the occupant and/or facility personnel, as is instruction ...

Method for the treatment of neurological or neuropsychiatric disorders

SYSTEMS AND METHODS FOR STIMULATION OF NEURONAL ACTIVITY

Systems and methods for stimulating a neuronal cell in the head of a patient in need of such stimulation are disclosed. The method includes positioning a light source proximal to the neuronal cell to be stimulated and pulsing the light from the light source to stimulate the neuronal cell for a predetermined period of time to achieve the desired effect.

ARTIFICIAL LIGHT APPARATUS AND ITS USE FOR INFLUENCING A CONDITION IN A SUBJECT

The present invention relates to an artificial light system for modulating circadian rhythms, increasing vigilance and influencing light-associated psychological conditions such as seasonal affective disorder. The system of the invention comprises a source of a green and/or red light and a source of blue light both light sources being controlled by a computer to provide predetermined light conditions. More specifically, the computer is programmed to provide pulses of blue light and continuous or pulsed red light, to enhance the efficacy of blue light, reduce blue-light hazard and avoid stroboscopic effect.

ASSESSMENT AND MODIFICATION OF CIRCADIAN PHASE AND AMPLITUDE

A method for accurately assessing and rapidly modifying the phase and amplitude of the endogenous circadian pacemaker is disclosed. A circadian cycle modification capacity assessment method comprises (before and after a stimulus) eliminating activityrelated confounding factors) associated with the sleeprest cycle which otherwise mask the state of the endogenous circadian pacemaker. Based on either individual or normative assessment data, the circadian phase and amplitude modification method involves the application of bright (about 9,500 lux) light and, advantageously, episodes of imposed darkness, at critically chosen phases to achieve rapid and stable changes in phase and amplitude. The timing of the episodes of bright light may be chosen either by reference to empirically-derived phase response data, or by using a mathematical model in which the endogenous circadian pacemaker is a van der Pol oscillator. A forcing function in the model is substantially proportional to changes in the ...

PORTABLE LIGHT UNIT FOR STIMULATING THE NEUROENDOCRINE SYSTEM AND ACHIEVING PHOTOTHERAPY FOR DEPRESSION

Light weight phototherapeutic devices are provided that emit an illuminance of at least 200 lux on the eyes of a wearer. The device is portable and can be used in the phototherapy of depressed patients, shift-workers and those affected by jet-lag and seasonal affective disorders.

THERAPEUTIC LAMP

A therapeutic lamp comprised of a fixture for retaining a light bulb in a position to be viewed by the eyes of a patient, apparatus for restricting the wavelengths of light emitted by the light bulb to those shorter than about 520 nanometers, and apparatus for restricting the light energy irradiance to between about 1.8 and 200 microwatts per square centimeter over at least the eyes of the patient. The restricting apparatus can be a narrowband light transmission filter. By the use of this lamp, the effects of seasonal effective disorder (SAD) is reduced or eliminated without substantially encountering the side effects of hypomania, irritability, nausea or agitation found using high intensity reduced spectrum or broad spectrum light.

LIGHT THERAPY DEVICE

FREQUENCY MODULATOR

A radiation device for therapeutic use in the human body allows the application of light waves to an affected area the body. A bulb, preferably a xenon bulb, produces light which is passed through a lens module having silicon and carbon granules therein. By applying different lenses to the device, a variation in the wavelength of light and radiation applied to an area is achieved. Each lens corresponds to a Shakra energy center. The device has a pistol-like housing to allow for controlled application of the radiation.

SYSTEM AND METHOD FOR STIMULATING ALERTNESS IN A SUBJECT

The present invention relates to a system for stimulating alertness in a subject within an environment exposed to an ambient light having a fluctuating ambient light illuminance. The system comprises an optical generator with a light source configured to generate a stimulating light having a stimulating light irradiance; and a driver coupled to the light source for controlling the stimulating light irradiance; an ambient light sensor configured to monitor the ambient light illuminance in real-time; and a controller operatively coupled to the optical generator and to the ambient light sensor to control the stimulating light irradiance in response to the ambient light illuminance monitored by the ambient light sensor, the controlling comprising capping the stimulating light irradiance to a maximal irradiance value based on the monitored ambient light illuminance. The present invention also relates to a method for stimulating alertness in a subject.

SYSTEMS AND METHODS FOR PREVENTING, MITIGATING, AND/OR TREATING DEMENTIA

The present disclosure provides systems and methods for at least one of preventing, reducing, and treating a level of or change in at least one of amyloid-ß (?ß) peptide, C-terminal fragment-ß (ß-CTF), ß-secretase (BACEl), ?-secretase, neuroinflammation, and/or dementia (e.g., Alzheimer's disease or age-related decline) in a subject by inducing synchronized gamma oscillations in the brain of the subject using, for example, a stimulus-emitting device to emit a stimulus (e.g., light, sound, and/or haptic) at a frequency (e.g., about 40 Hz) that synchronously activates in vivo a specific cell type (e.g., fast-spiking-parvalbumin (FS-PV) immunoreactive interneurons) and/or brain region (e.g., a sensory cortex and/or hippocampus) of the subject.

METHODS AND SYSTEMS FOR NEURAL STIMULATION VIA VISUAL STIMULATION

Systems and methods of the present disclosure are directed to systems and methods for treating cognitive dysfunction in a subject in need thereof. The system can include eyeglasses, a photodiode positioned to detect ambient light, light sources, and an input device. The system can include a neural stimulation system that retrieves a profile and selects a light pattern having a fixed parameter and a variable parameter. The neural stimulation system can set a value of the variable parameter of the light pattern, construct an output signal, and then provide the output signal to the light sources to direct light towards the fovea.

DEVICE FOR BIOSTIMULATING PHOTOTHERAPY

The invention relates to a device (1) for biostimulating phototherapy, in particular in conjunction with a therapy appliance (50). The device comprises at least one first light-emitting unit (4.1, 4.2) for directly and/or indirectly applying light of a first wavelength to at least one part of a human or animal body, and a control unit (2) for outputting application routines. The device also comprises a module interface (3.1, 3.2) for operatively connecting the control unit to the at least one first light-emitting unit (4.1, 4.2), and a core interface (5) for operative connection to a therapy appliance (50). The control unit (2) is designed such that it is able to receive data via the core interface (5) and, on the basis of these data, is able to control the output of an application routine via the module interface (3.1, 3.2). The invention also relates to: a therapy appliance fitted with the device according to the invention, for physical treatment of a patient using enhanced biostimulating ...

RESTRUCTURING NEURAL PATHWAYS IN THE BRAIN WITH A COMBINATION OF TRANSCRANIAL THERAPIES

Brain dysfunction can be treated by restructuring neural pathways in the brain. A desired area in the brain to form a new neural pathway is selected. The area receives a sequential combination of (1) transcranial photobiomodulation therapy (PBMT) including a series of pulses having a frequency matched to a target brain wave and (2) another transcranial stimulation (e.g., transcranial direct current electrical stimulation and/or transcranial magnetic stimulation). The different stimulation mechanisms ensure that neuroplasticity occurs to restructure a neural pathway that is dysfunctional in nature to a new neural pathway that conducts normally.

ILLUMINATION APPARATUS

The present invention relates to an illumination apparatus (100). The illumination apparatus (100) comprising: a first light source (102) configured to emit light having a first spectral light distribution having a first main light intensity peak about a first peak wavelength providing light stimulation, and a second light source (104) configured to emit light having a second spectral light distribution having a second main light intensity peak about a second peak wavelength being different from the first peak wavelength, a third light source (106) configured to emit light having a third spectral light distribution having a third main light intensity peak about a third peak wavelength being different from the first peak wavelength and from the second peak wavelength, wherein the illumination apparatus (100) is configured to provide adjustment of light intensity of the first light source (102) and of light of the second light source (104), thereby providing a relative light intensity between ...

AMBIENT SPECTRUM LIGHT CONVERSION DEVICE

Apparatus and methods to enhance light intensity within useful red to near-infrared spectral ranges, using direct or indirect sunlight, or from other ambient white light, are described. The disclosed devices provide high quantum yield photoluminescent ambient light spectrum conversion to increase the supplied energy primarily in the 590nm-850nm spectral range. These devices also pass much of the incident light in the spectral range in which the device's photoluminescent materials emit light, thereby greatly increasing the effective intensity of light available in the targeted 590-850nm wavelength range. The ambient light conversion devices of the disclosure may be incorporated in apparel, bandage-like patches, converting reflectors, large area converters, awnings, window covers, and other articles, materials, and products. The converted light may be used in therapeutic treatments, horticultural and biotechnological applications, and other applications in which the converted light outputs ...

AMBIENT LIGHTING SYSTEM TO MITIGATE THE IMPACT OF TRAVEL ACROSS TIME ZONES

A system and method for a customized ambient lighting environment for individuals in vehicles travelling rapidly across multiple time zones, that can be automated and/or based on user input and which allows each user to be exposed to light in accordance to selected preferences and circumstances, in order to begin acclimating the user to a new time zone, or avoid acclimating to a new time zone, and/or otherwise mitigate circadian desynchrony.

REARING METHOD FOR GROWING CATTLE

A rearing method for growing cattle are provided that can enhance the appetite for feed, without greatly disturbing the circadian rhythm. The rearing method for growing cattle are a method based on a circadian cycle under a long-day management that manages the growing cattle in a lighting environment in which a light period is longer than a dark period. The light period includes a first period during which the growing cattle are irradiated with light including blue light, and a second period following the first period, during which the growing cattle are irradiated with light not including blue light, but including amber light.

OPTOGENETIC CONTROL OF REWARD-RELATED BEHAVIORS

Provided herein are compositions and methods for disrupting at least one reward- related behavior in an individual through the use of light-responsive opsin proteins used to control the polarization state of the cholinergic intemeurons of the nucleus accumbens or the striatum.

PULSED ENERGY STIMULATOR DEVICE

The present invention relates to a device for stimulation of an individual`s skin for beneficial cosmetic or therapeutic purposes. The device synchronously produces pulsed, electrical, magnetic and light energy fields on the area to be treated through a transparent electrical insulating shield and simultaneously passes charged ions over that area.

Expansion space in the Columns-concept.

Ein Entspannungsraum (1) mit zur Erzeugung verschiedenartiger Reize eines Menschen (2) ausgebildeten Einrichtungen sowie mit einem begehbaren Innenraum (4), wobei sich in diesem zumindest drei Wassersäulen (5) befinden, die bezüglich ihres Füllstands (6) schwingungsfähig gekoppelt sind.

Expansion space in the flux-concept.

Ein Entspannungsraum (1) mit zur Erzeugung verschiedenartiger Reize eines Menschen (2) ausgebildeten Einrichtungen sowie mit einem begehbaren Innenraum (4), wobei dessen Randflächen (5) zumindest teilweise mit durchleuchteten Rohrleitungen (6) umspannt sind, welche mit Wasser durchströmt sind.

Device for the treatment of a person with visible light.

Eine erfindungsgemässe Vorrichtung (1) zur Behandlung einer Person mit sichtbarem Licht umfasst ein Gestell (5) und eine Mehrzahl von Leuchtelementen (25), welche auf dem Gestell angebracht sind, und welche dazu eingerichtet sind, Licht im sichtbaren Bereich abzugeben. Das Gestell weist einen balkenförmigen Mittelteil (6) und zwei balkenförmige Seitenteile (12, 12´) auf, wobei die beiden Seitenteile kürzer sind als das Mittelteil, an je einem Längsende (9, 9´) des Mittelteils angeordnet sind, und mit dem Mittelteil einen Winkel zwischen 60° und 120° einschliessen. Die Leuchtelemente sind derart auf einer Vorderseite des Mittelteil und der Seitenteile angeordnet, dass sie Licht in einen durch das Mittelteil und die Seitenteile umschlossenen Bestrahlungsbereich (26) abstrahlen können.

Device for treating subject using visible light, has light-emitting elements which are arranged on the front side of center and side portions such that both the portions are surrounded by the light emitted in irradiation area

The device (1) has a frame mounted with several light emitting elements (25). The frame has a central portion (6), and two bar-shaped side portions (12,12') which are shorter than the central portion such that the respective longitudinal ends (9,9') of central portion are set enclosing an angle in the range of 60-120[deg] . The light-emitting elements are arranged on the front side of center portion and side portions such that central and side portions are surrounded by the light emitted in an irradiation area (26). The device has a seat and/or a couch made of Plexiglas.

Chromotherapy aid is constituted by dress which has at least one portion permeable to light

The chromatherapy aid is constituted by a dress (2) which has at least one portion (4) permeable to light. This allows chromotherapy to be effected during the entire activities of the wearer (1) during the whole day. The permeable portion comprises an insert (5) of plastic material, duly colored.

Expansion space in the torus-concept.

Ein Entspannungsraum (1) mit zur Erzeugung verschiedenartiger Reize eines Menschen (2) ausgebildeten Einrichtungen sowie mit einem begehbaren Innenraum (4) mit einer Innenrandfläche (5), wobei der Innenraum (4) die Topologie eines Ringtorus mit einem durchgehenden Torusloch (9) in der Mitte aufweist.

Lighting device for subjecting a user's eyes to light continuously or discontinuously and relaxation process of using such a device.

Linvention concerne un dispositif déclairage pour exposer les yeux dun utilisateur à une lumière discontinue alternant des phases lumineuses et des phases dobscurité. Le dispositif comprend au moins un moyen démission de lumière (12) diffusant une lumière rouge de longueur donde sensiblement égale à 640 nm dans le champ de vision de lutilisateur et un moyen de contrôle couplé audit moyen démission de lumière. Le moyen de contrôle est apte à faire varier de manière périodique lintensité I de la lumière émise par ledit moyen démission de lumière dune valeur sensiblement égale à 0 à une valeur maximale I max et réciproquement. Linvention concerne également une méthode de relaxation basée sur lutilisation du dispositif déclairage de la présente invention.

Lighting device for subjecting a user's eyes to light continuous or discontinuous.

Linvention concerne un dispositif déclairage pour exposer les yeux dun utilisateur à une lumière discontinue alternant des phases lumineuses et des phases dobscurité. Le dispositif comprend au moins un moyen démission de lumière (12) diffusant une lumière rouge de longueur donde sensiblement égale à 640 nm dans le champ de vision de lutilisateur et un moyen de contrôle couplé audit moyen démission de lumière. Le moyen de contrôle est apte à faire varier de manière périodique lintensité I de la lumière émise par ledit moyen démission de lumière dune valeur sensiblement égale à 0 à une valeur maximale Imax et réciproquement.

Illumination device i.e. surface-emitting diode for use as decorative element, has front panel covering light radiation opening in housing, where front panel is formed in single- or multi-color or provided with colored pattern

The device has a light source arranged in a housing (1) with a light radiation opening that is covered by a partially transparent front panel (2). The housing has a relative surface shape with reduced depth with respect to dimensions of the opening. The light source is formed as an intensive light source with luminosity of 6000 lumens, and the front panel is formed in single- or multi-color or provided with a colored pattern. The front panel is detachably attached at the housing without requiring tools.

Bench seat having a back portion and a movable back element.

Die Erfindung betrifft eine Sitzbank (1), insbesondere für eine Sauna- oder Infrarotkabine (100), mit einem Rückenteil (2) und einer Längsrichtung (X), wobei zumindest ein Rückenelement (3) am Rückenteil (2) in Längsrichtung (X) der Sitzbank (1) beweglich – vorzugsweise verschiebbar – gelagert ist und zumindest einen elektrischen Verbraucher (4) enthält. Weiter betrifft die Erfindung auch eine Sauna- oder Infrarotkabine mit der oben genannten Sitzbank.

Biostimulating phototherapy device.

Die Erfindung betrifft eine Vorrichtung (1) zur biostimulierenden Phototherapie, insbesondere in Verbindung mit einem Therapiegerät (50). Die Vorrichtung umfasst mindestens eine erste Lichtemissionseinheit (4.1, 4.2) zur direkten und/oder indirekten Beaufschlagung mindestens eines Teils eines menschlichen oder tierischen Körpers mit Licht einer ersten Wellenlänge, und eine Steuerungseinheit (2) zur Ausgabe von Beaufschlagungsroutinen. Die Vorrichtung umfasst weiter eine Modul-Schnittstelle (3.1, 3.2) zur Wirkverbindung der Steuerungseinheit mit der mindestens einen erste Lichtemissionseinheit (4.1, 4.2), sowie eine Kern-Schnittstelle (5) zur Wirkverbindung mit einem Therapiegerät (50). Sie Steuerungseinheit (2) ist so ausgelegt, dass sie Daten über die Kern-Schnittstelle (5) zu empfangen, und in Abhängigkeit dieser Daten die Ausgabe einer Beaufschlagungsroutine über die Modul-Schnittstelle (3.1, 3.2) zu steuern vermag. Die Erfindung betrifft weiter ein mit der erfindungsgemässen Vorrichtung ...

Verwendung von Cannabinoiden in Therapie- und Wellnessgeräten.

Die vorliegende Erfindung betrifft eine Vorrichtung zur Beaufschlagung eines menschlichen Körpers mit Energie. Die Vorrichtung umfasst eine Kontaktfläche 2, welche einen Beaufschlagungsbereich definiert, in welchem ein menschlicher Körper in den Wirkbereich der Energie platzierbar ist. Sie umfasst weiter mindestens ein Mittel zur Abgabe der im Wesentlichen auf den Beaufschlagungsbereich gerichteten Energie, und mindestens ein Mittel zur Erzeugung eines Dampfgemisches umfassend mindestens ein Cannabinoid. Die erfindungsgemässe Vorrichtung umfasst zudem mindestens ein Mittel, um das Dampfgemisch mit einer Effektivdosis mindestens eines Cannabinoids in das Umfeld der Atemöffnungen eines menschlichen Körpers zu führen. Weiter betrifft die vorliegende Erfindung ein Verfahren zum Betreiben einer solchen Vorrichtung, sowie die Verwendung von Dampfgemischen umfassend mindestens ein Cannabinoid in bezeichneten Vorrichtungen.

Vorrichtung zur Beaufschlagung eines menschlichen Körpers oder von Teilen eines menschlichen Körpers mit medizinisch-kosmetischer Strahlung.

Die vorliegende Erfindung betrifft eine Vorrichtung zur Beaufschlagung eines menschlichen Körpers oder Teilen davon mit medizinisch-kosmetischer Strahlung. Besonders bevorzugt handelt es sich dabei um optische Strahlung. Die erfindungsgemässe Vorrichtung (1) umfasst mindestens ein erstes Leuchtmittel (2) zur Erzeugung der medizinisch-kosmetischen Strahlung. Sie umfasst weiter einen ersten Lüftungsstrom zur Kühlung eines Leuchtmittels, und einen zweiten Lüftungsstrom zur Kühlung des menschlichen Körpers oder Teilen des menschlichen Körpers. Die erfindungsgemässe Vorrichtung umfasst mindestens eine Klimaanlage (6) in Fluidverbindung mit dem zweiten Lüftungsstrom, und ausgelegt zur klimatechnischen Behandlung des Lüftungsstroms und ist dadurch gekennzeichnet, dass die Vorrichtung weiter mindestens eine Desinfektionskammer (7) aufweist, die in Fluidverbindung mit dem zweiten Lüftungsstrom steht und ausgelegt ist, eine physikalische Desinfektion des zweiten Lüftungsstroms durchzuführen. Die ...

INTERACTIVE LIGHT FIELD DEVICE AND METHOD OF FORMING INTERACTIVE LIGHT FIELD

РУЧНОЕ УСТРОЙСТВО И СПОСОБ СВЕТОЛЕЧЕНИЯ

Предлагается устройство для светолечения с подведением света через глаза к пациенту для лечения расстройств, которые поддаются глазному светолечению, при этом, устройство содержит источник питания и ручное светоизлучающее устройство. Светоизлучающее устройство содержит множество источников света, работающих от источника питания. Предлагается способ светолечения, в котором свет подводят через глаза к пациенту для лечения расстройств, которые поддаются глазному светолечению. Способ заключается в том, что подводят свет к глазам пациента посредством ручного источника света, работающего от источника питания.

Device for using saved frequency information

The invention relates to a device for using saved frequency information in the form of modulated magnetic fields and/or modulated light to the body. Said device comprises at least one transceiver, a display (2), a memory, control electronics, a digital-analogue converter and a coil (6) for applying the modulated magnetic fields and/or a laser (7) for applying modulated light. The invention also relates to a method for tapping signals of the electric potential of the heart and the pulse value and using saved frequency information by means of a device according to the invention.

EXPOSURE METHOD OF A LIVING BODY TO MONOCHROMATIC LIGHT RAYS AND MEANS FOR CARRYING THE [...].

DISPOSITIF POUR HARMONISER OU REHARMONISER L'ENERGIE VITALE COSMIQUE CHEZ L'ETRE HUMAIN.

Procédé permettant à l'être humain d'harmoniser ou de réharmoniser en lui l'énergie vitale cosmique. L'invention se présente sous la forme d'un masque reposant sur la face, englobant les yeux et le nez. L'appareil permet la visualisation d'écrans translucides amovibles colorés 1 en vision mono ou binoculaire par l'intermédiaire de cloisons amovibles internes 4. La respiration de l'expérimentateur s'effectue par l'intermédiaire d'orifices 2 percés dans le masque et un ou plusieurs haut-parleurs solidaires de l'appareil permettent l'écoute de sons ou de musique transmettant leur énergie à l'air respiré. (CF DESSIN DANS BOPI) ...

DEVICE OF PHOTOSTIMULATION

La présente invention concerne un dispositif pour éclairer un œil de manière homogène, comprenant : - une source de lumière (3) ; - un premier guide de lumière (1) qui est connecté de manière optique à ladite source de lumière et comprend une pluralité de facettes réfléchissantes (4) estampées dans le guide de lumière, le nombre, les orientations angulaires et les dimensions de ces facettes étant agencés pour extraire de la lumière ayant une répartition uniforme dans une direction essentiellement perpendiculaire au premier guide de lumière ; - un deuxième guide de lumière (2) qui est connecté de manière optique au premier guide de lumière (1) et comprend une pluralité de facettes réfléchissantes (6) estampées dans le deuxième guide de lumière, le nombre, les orientations angulaires et les dimensions de ces facettes étant agencés pour produire en cours d'utilisation une répartition uniforme de la lumière dans une direction orientée vers l'œil (8) ; - des moyens pour immobiliser le dispositif ...

APPAREIL A EMISSION LUMINEUSE AYANT UN EFFET PHYSIOLOGIQUE PAR VOIE CUTANEE

CET APPAREIL COMPREND UN BOITIER 1 PERCE A L'AVANT D'UNE FENETRE; UN DISPOSITIF ELECTRIQUE APPELE CLIGNOTEUR CONSTITUE D'UN CIRCUIT ELECTRIQUE 17, DE PILES D'ALIMENTATION 23 A 25 ET D'UNE LAMPE 26; UN SUPPORT 15 POUR LE DISPOSITIF ELECTRIQUE, FIXE DANS LE BOITIER DE TELLE SORTE QUE LADITE LAMPE SOIT DIRIGEE VERS LADITE FENETRE; ET AU MOINS UN FILTRE COLORE. L'APPAREIL EST FERME A L'ARRIERE PAR UN COUVERCLE 3 AMOVIBLE ET IL COMPREND EN OUTRE UN ENSEMBLE CONSTITUE D'AU MOINS UN FILTRE COLORE 32, 33 ET D'UNE COUCHE DE TISSU 34 PLACEE EN AVANT DU FILTRE ET IMPREGNEE DE SUBSTANCES ACTIVES DILUEES ET DYNAMISEES SELON LES METHODES D'HAHNEMANN, CET ENSEMBLE ETANT MAINTENU EN PLACE DANS LE BOITIER ENTRE LA FENETRE ET LA LAMPE; LES TEMPS D'ILLUMINATION ET D'EXTINCTION SONT DE 1 A 3S, LA PERIODE DE CLIGNOTEMENT ETANT DE 2 A 6S. UN DIAPHRAGME PEUT ETRE ADJOINT. APPLICATION: EFFET SOPORIFIQUE, OU ANTI-TABAGIQUE, OU RELAXANT, OU DYNAMISANT, ENTRE AUTRES, SUIVANT LES FILTRES, LES SUBSTANCES ACTIVES, LES ...

DEVICE AND PROCESS OF REDUCTION IN FLIGHT OF THE SYNDROME OF THE JET LAG

L'invention concerne un dispositif (1) de réduction du syndrome du décalage horaire, configuré pour être intégré dans un aéronef (2), ledit dispositif (1) étant caractérisé en ce qu'il comprend : - un ensemble de stimulateurs (4) sensoriels comprenant au moins une source (3) d'émission de lumière, o lesdits stimulateurs sensoriels étant aptes à émettre des stimuli sensoriels vers un passager lors du vol de l'aéronef (2), - un processeur (10) configuré pour contrôler l'émission des stimuli sensoriels pour la réduction du syndrome du décalage horaire subi par le passager, en fonction de données (21) comprenant des données (25) comportementales du passager.

Color thrapy massage chair for relieving stress

광 요법을 위한 동력공급형 안과용 장치의 형성을 위한 장치 및 방법

... 본 발명은 착용자의 눈에 특정 대역폭의 광을 제공할 수 있는 광원(202a)을 구비한 안과용 렌즈(201)를 제공하기 위한 방법 및 장치를 개시한다. 일부 실시예에서, 안과용 렌즈(201)는 실리콘 하이드로겔로부터 캐스트 성형되고 에너지 공급원(202) 및 광원(202a)이 안과용 렌즈(201) 내에 봉지된다.

HEAD FOR BEAUTY DEVICE USING HEAT

The present invention relates to a head for a beauty device using heat. The head for the beauty device using the heat comprises: a front case; a rear case; a hand current carrying unit; a PCB; a head module for local skin care; a heater; and a motor. An input switch is combined with the front case to be exposed to the outside. The rear case is detached from the front case; and mounts a plurality of components which are interposed between the front case and the rear case. The hand current carrying unit is provided on one side of the front case and the rear case. The PCB controls a heating mode, a whitening mode, an anti-aging mode, and a lifting mode; and includes a battery and a plurality of LEDs. The head module for the local skin care is combined with front sides of the front case and the rear case to facilitate the local skin care. The heater is arranged between the front case and the rear case, and provides heat to the head module for the local skin care. The motor is connected to one ...

NURIE COLOR THERAPY VERIFICATION SYSTEM REFLECTING INDIVIDUAL COLOR SENSITIVITY

METHODS FOR PREVENTING AND TREATING MOTOR-RELATED NEUROLOGICAL CONDITIONS

fonte de iluminação led para desempenho cognitivo melhorado e com propriedades de luz solar

PROGRAMMABLE MULTIFUNCTION TABLE LAMP FOR LIGHT THERAPY

A lamp for providing light therapy includes an input circuit, an output circuit, and a signal processing circuit. The input circuit may include a user input for providing control signals to the signal processing circuit based on input at the user input from a user. The output circuit may include a light output configured to emit light at a level of at least 2,500 lux. The light output may include one or more white LEDs and may also include one or more color LEDs. The signal processing circuit is connected to the input circuit and the output circuit, and receives the control signals from the input circuit to control the output circuit based on the control signals. A memory may be provided in communication with the signal processing circuit. The memory may store a plurality of output modes, such as a light therapy mode. The light output may include a diffuser that is configured to diffuse the high-intensity light for effective use.

PHOTO-STIMULATION DEVICE

The present invention is related to a device for performing a homogeneous illumination of an eye comprising: - a light source (3); -a first light guide (1) that is optically connected to said light source and comprising a plurality of reflecting facets (4) embossed in the light guide, the number, angular orientations and sizes of those facets being arranged for extracting light having a uniform distribution in a direction essentially perpendicular to the first light guide; - a second light guide (2) that is optically connected to the first light guide (1) and comprising a plurality of reflecting facets (6) embossed in the second light guide, the number, angular orientations and sizes of those facets being arranged for producing in use a uniform light distribution in a direction oriented towards the eye (8); - means for immobilizing the device on the head of a user.

SYSTEM AND METHOD FOR TREATING SYMPTOMS OF RESTLESS LEGS SYNDROME

Disclosed herein are systems and methods for reducing effects of restless legs syndrome (RLS) in a subject. The method includes identifying, on the subject, a body region affected by RLS, placing an emitter unit in direct contact with skin of the body region, wherein the emitter unit includes at least one emitter that emits near-infrared light, and activating the emitter to emit an effective amount of near-infrared light for inducing release of nitric oxide from hemoglobin or generation in the endothelium. Also disclosed is an emitter unit that is placed in direct contact with a subject's skin associated with RLS to reduce the effects of RLS. The emitter unit emits an effective amount of near-infrared light directed to the subject's skin to induce release of nitric oxide from hemoglobin or generation in the endothelium, and a module configured to toggle the emitter unit between a transmitting and a nontransmitting mode.

PORTABLE LIGHT UNIT FOR STIMULATING NEUROENDOCRINE SYSTEM

Light weight phototherapeutic devices are provided that emit an illuminance of at least 200 lux on the eyes of a wearer. The device is portable and can be used in the phototherapy of depressed patients, shift-workers and those affected by jet-lag and seasonal affective disorders.

METHOD OF AND DEVICE FOR THERAPEUTIC ILLUMINATION OF INTERNAL ORGANS AND TISSUES

Methods and devices for intracorporeal therapeutic illumination using an implantable light source are disclosed. The present invention can be used for short, intermediate and/or long-term light therapy of all internal tissues, organs and organ surfaces, including the blood, in the treatment of inflammatory, infectious, arthritic, allergic, musculoskeletal and parasitic pathologies. The implantable light source comprises a wide range of modifiable wavelengths and other light therapy parameters and can illuminate remote intracorporeal locations via optional fiber optic connection. Direct phototherapy of the blood is effected by implantable intravascular light sources, optical fiber conduits, a unique light source-bearing intravascular tubular platform or a novel, light emitting vascular prosthesis. Power and modulation of the light therapy parameters is provided by implantable power and control modules or, in preferred embodiments, by external sources in telemetric communication with the ...

BRAIN WAVE STIMULATOR

A brain wave stimulator comprises a frequency-control device and pulse-shaping and pulse-processing units which emit acoustic, optical, electrical and/or electromagnetic or mechanical pulse signals. To ensure precise, reproducible control, the stimulator comprises a quartz-stabilized oscillating circuit (1) and a frequency-divider module (2) connected downstream of the oscillating circuit (1) for setting a frequency. The frequency-divider module (2) is connected by a switch (S1) to a programmable, digital frequency divider (3) downstream of which are connected two other frequency dividers (4, 5) connected in series, each having two outputs. These outputs are connected by coupled switches (S2, S3) of different frequencies to pulse-shaping units (7, 8, 9, 10) for various applicators (20, 21, 22, 23).

SYSTEM FOR DELIVERING ELECTROMAGNETIC RADIATION TO THE EYEBALL OF A SUBJECT

Light therapy is provided to a subject using a system and/or method. The light therapy includes the administration of electromagnetic radiation to the eyeball of the subject underneath the eyelid of the subject while the eyelid of the subject is closed (e.g., as the subject sleeps). The light therapy algorithm may be designed to impact melatonin and/or serotonin levels within the body of the subject in a therapeutically beneficial manner. For example, the light therapy algorithm may be designed to impact melatonin and/or serotonin levels to treat one or more of a sleep and/or mood disorder (e.g., seasonal affective disorder, non-seasonal depression, Circadian rhythm disruption), or other disorders treatable with control over melatonin and/or serotonin levels in the body.

PHOTORECEPTOR SYSTEM FOR MELATONIN REGULATION AND PHOTOTHERAPY

The present invention involves a light system for stimulating or regulating neuroendocrine, circadian, and photoneural systems in mammals based upon the discovery of peak sensitivity ranging from 425-505 nm; a light meter system for quantifying light which stimulates or regulates mammalian circadian, photoneural, and neuroendocrine systems. The present invention also relates to translucent and transparent materials, and lamps or other light sources with or without filters capable of stimulating or regulating neuroendocrine, circadian, and photoneural systems in mammals. Additionally, the present invention involves treatment of mammals with a wide variety of disorders or deficits, including light responsive disorders, eating disorders, menstrual cycle disorders, non-specific alerting and performance deficits, hormone-sensitive cancers, and cardiovascular disorders.

LUMINOUS ROOF FOR NICU INCUBATORS FOR REGULATING CIRCADIAN RHYTHMS IN INFANTS AND FOR PROVIDING HIGH VISIBILITY OF INFANT ANATOMY FOR HEALTHCARE STAFF

Multipurpose lighting systems and methods of providing controllable lighting are provided. A lighting system includes a sheet of flexible material, a plurality of light sources and a controller. The plurality of light sources are attached to the sheet of flexible material and configured to emit diffused light. The controller is coupled to the plurality of light sources and is configured to control one or more of the plurality of light sources according to one of a plurality of prescribed lighting characteristics associated with a respective plurality of different lighting tasks. In some examples, the lighting system includes a camera coupled to the sheet of flexible material configured to capture at least one image of an object synchronously with the light emitted by the plurality of light sources.

High Powered Light Emitting Diode Photobiology Device

A high-powered light emitting diode (LED) photobiology (phototherapy) device is disclosed in the accompanying specification. The contemplated photobiology (phototherapy) device may be used in the treatment of various aesthetic and medical or other conditions. The phototherapy device may include a number of select LEDs for emitting a desired range or ranges of wavelengths of high intensity light for use in treatment. Additionally, the phototherapy treatment includes one or more methods for providing a treatment appropriate to the condition desired to be treated. The phototherapy device provides for a variety of high power light settings, intensity levels, and selectable time intervals for providing treatment.

System and method for delivering electromagnetic radiation to the eyeball of a subject

Light therapy is provided to a subject using a system and/or method. The light therapy includes the administration of electromagnetic radiation to the eyeball of the subject underneath the eyelid of the subject while the eyelid of the subject is closed (e.g., as the subject sleeps). The light therapy algorithm may be designed to impact melatonin and/or serotonin levels within the body of the subject in a therapeutically beneficial manner. For example, the light therapy algorithm may be designed to impact melatonin and/or serotonin levels to treat one or more of a sleep and/or mood disorder (e.g., seasonal affective disorder, non-seasonal depression, Circadian rhythm disruption), or other disorders treatable with control over melatonin and/or serotonin levels in the body.

Low-level energy laser therapy

Methods and systems ( 10, 54, 72 ) are provided for administering phototherapy to an injured tissue in a living subject by delivering visible or infrared biostimulatory energy to bone marrow at a dose sufficient to cause mesenchymal stem cells to appear in the injured tissue. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe ( 74 ). The technique is useful for treating many types of tissue injury, including ischemic cardiac and renal conditions.

Methods and devices for visible light modulation of mitochondrial function in hypoxia and disease

The present invention provides methods of using electromagnetic radiation in the visible portion of the spectrum to modulate mitochondrial function in the treatment of various conditions, including Alzheimer's disease, other demential, hypoxia and diabetic peripheral neuropathy, and sensory disorders of the extremities.

Multiple device storefront for video provisioning system

A system may process metadata associated with video assets; generate, based on the metadata, a first listing of the video assets, where the first listing is compatible with a first type of user device that corresponds to a set top box; and provide the first listing to the first type of user device. The system may further generate, based on the metadata, a second listing of the video assets, where the second listing is formatted to be compatible with a second type of user device that is a different type than the set top box; and provide the second listing to the second type of user device.

Catalog slicing in a video provisioning system

A system, associated with a video provisioning system, may receive a hierarchical representation of categories and subcategories associated with a catalog of video assets; and condense the hierarchical representation of categories and subcategories into a file. The system may further transmit the file to a set top box, where transmitting the file allows the set top box to access the hierarchical representation of categories and subcategories without retrieving, from the video provisioning system, additional information associated with the hierarchical representation of categories and subcategories.

System and method for administering light therapy

A sleep mask is configured to provide light therapy to a subject. The sleep mask may provide a comfortable delivery mechanism for the light therapy, and may deliver the light therapy to the subject while the subject is asleep, in the process of going to sleep, and/or waking from sleep. In one embodiment, the sleep mask includes one or more of a shield, a strap, a first lighting module, and/or a second lighting module.

Light therapy device

A light therapy device includes a number of light emitting elements, a detection module, a determination module, and a control module. The detection module is configured to detect a body parameter of a human body. The determination module is in communication with the detection module and configured to receive the body parameter and output a fatigue level corresponding to the body parameter. The control module is in communication with the determination module and the light emitting elements. The control module is configured to receive the fatigue level and control the light emitting elements to emit lights with an irradiation intensity for a preset period of time in response to receiving the fatigue level. The irradiation intensity and the preset period of time have a predetermined relationship with the fatigue level.

Device for Preventing or Ameliorating Seasonal Affective Disorder

An array of blue-emitting LEDs centered at about 460 nm, with a gaussian distribution of plus-or-minus 20 nm. are housed in an elongated housing and powered from a standard USB cable or equivalent DC power source. The user can select between a higher and lower intensity. The blue wavelengths in this range are very effective for cirtopic receptors of the eye, with little impact upon visual receptors (i.e., rod cells and cone cells). This allows optimal therapeutic effect with minimal visual side effects.

Method and system for facilitating adjusting a circadian pacemaker

A method and system for facilitating adjusting a user's circadian pacemaker are provided, including determining a current circadian pacemaker state of the user, as well as potential future states of the user's circadian pacemaker. The potential future states are related to a target circadian pacemaker state representing a circadian pacemaker goal for the user. This is accomplished on a state-variable plane using vectors. An optimum potential future state is selected as a basis for constructing a light exposure treatment schedule for the user. A light exposure treatment schedule is then constructed and provided to the user to facilitate taking control of the user's circadian pacemaker and manipulating it for benefits such as health and performance benefits.

Fibers in therapy and cosmetics

The present invention relates inter alia to functional materials for the treatment and/or prophylaxis and/or diagnosis of diseases and/or cosmetic conditions. The functional materials can be used for the preparation of light emitting devices comprising fibers as light emitting elements.

Efficient circadian and related system modulation with a sleep mask

Light therapy is provided to a subject through a sleep mask. The sleep mask is configured to deliver electromagnetic radiation to the closed eyelids of the subject within a defined optimal wavelength band that is therapeutically impactful in modulating circadian and related systems of the subject.

METHOD OF TREATING MULTIPLE SCLEROSIS

A method and computer program product for suppressing the symptoms of multiple sclerosis (MS) by irradiating a subject exhibiting the symptoms with a predetermined dose of UV-containing light from a light source and detecting a suppression of the clinical symptoms of MS. In particular, the detected suppression of the clinical symptoms is disassociated from the vitamin D production within the subject. 1. A method for suppressing clinical symptoms of multiple sclerosis (MS) in a subject , the method comprisingirradiating the subject with an effective first dose of light from a light source; wherein the dose is effective to suppress multiple sclerosis symptoms, anddetecting a suppression of the clinical symptoms in the subject.2. A method according to claim 1 , further comprising identifying the subject with the use of pre-defined diagnostic criteria.3. A method according to claim 1 , wherein the suppression of the clinical symptoms includes at least one of a delay of onset of MS symptoms claim 1 , a reduction of peak of severity of MS symptoms claim 1 , and a decrease of the cumulative disease index (CDI).4. A method according to claim 1 , wherein the method additionally comprises a second light dose.5. A method according to claim 1 , wherein the irradiating includes repeatedly irradiating with such a dose and at such repetition time intervals as to suppress clinical symptoms and wherein the subject does not develop hypercalcemia.6. A method according to claim 1 , additionally comprising the step of irradiating the subject with a second dose of light claim 1 , wherein each of the first and second doses of light comprises a UV irradiance of at least 2.5 kJ/m.7. A method according to claim 1 , wherein the subject is has a reference level of serum calcium and a reference level of a serum 25(OH)D3 claim 1 , and wherein the irradiating the subject includesa) irradiating the subject with a first dose of light from a light source, the first dose being adapted to cause a ...

Bone Conduction Apparatus and Multi-sensory Brain Integration Method

The present disclosure provides a therapeutic method applicable to learning, attention, cognitive and developmental disorders. This method combines auditory, visual and vestibular stimuli into a systematic method which can be customized to address individual learning, attention and processing disorders. This method may be wirelessly implemented in a group setting. A device for providing vestibular and somatosensory stimulation through bone conduction of sound waves to skeletal bones is provided in the form of a pad that is applied to or wrapped around the individual in treatment, which is comfortable in use and may contain particulate filler material capable of providing bone conduction stimulation adjacent to the location of a bone conduction transducer and expand the sound conduction site over a larger area. 1. A method for the enhancement of sensory processing and sensory integration , comprising:filtering a composition, comprising music and sounds, to change the relative amplitude of certain frequency ranges associated with the composition,delivering said filtered sound composition to a subject through air conduction audio speakers,transmitting wirelessly, to a plurality of bone conduction headphones, a bone conduction signal derived from said filtered sound composition.2. The method of claim 1 , wherein said filtering said sound composition to change the amplitude of certain frequency ranges comprises increasing the amplitude of frequency sound waves below 750 Hz.3. The method of claim 1 , wherein said filtering said sound composition to change the amplitude of certain frequency ranges comprises reducing the amplitude of frequency sound waves below 750 Hz.4. The method of claim 1 , further comprising:wherein said filtering said sound composition to change the amplitude of certain frequency ranges comprises reducing the amplitude of lower frequency sound waves below 4,000 Hz.5. The method of claim 1 , further comprising:wherein said filtering said sound ...

DEVICE AND METHOD FOR ALTERING NEUROTRANSMITTER LEVEL IN BRAIN

The present disclosure relates to a device and a method for non-invasively applying optical radiation to photosensitive parts of the brain. In particular the present invention is directed to a device for non-invasive/trans-cranial light therapy comprising one or more radiation units adapted to direct optical radiation at one or more neuroanatomical brain structures of a user from at least one extra-cranial position below the cerebrum of the user, said device applied for use in altering and/or controlling the production, release, re-uptake and/or metabolism of dopamine or serotonin in at least one of said one or more neuroanatomical brain structures and/or in the body of the user. 1. A device for non-invasive/trans-cranial light therapy comprising at least one radiation unit adapted to direct optical radiation toward at least one neuroanatomical brain structure of a user from at least one extra-cranial position below the cerebrum of the user , said device applied for use in at least one of altering and controlling at least one of the production , release , re-uptake , and metabolism of serotonin in at least one of said at least one neuroanatomical brain structure and in the body of the user.2. The device according to claim 1 , wherein said at least one extra-cranial position is non-ocular.3. The device according to claim 2 , wherein said at least one extra-cranial position is the auditory canal.4. The device according to claim 1 , further comprising a housing in at least one of optical and electrical connection with said at least one radiation unit and with at least one light source claim 1 , such as an LED claim 1 , for generating the optical radiation.5. The device according to claim 1 , further comprising means for adapting at least one of the intensity claim 1 , the radiant flux claim 1 , the luminous flux claim 1 , and the spectral power of the optical radiation emitted from said at least one radiation unit.6. The device according to claim 1 , further comprising ...

HEAD MOUNTED LIGHT THERAPY DEVICE

A portable, lightweight, head-mounted light therapy device is disclosed. The device comprises an one or more selectable light sources, such as light emitting diodes (LEDs), to provide bright or dim red light, bright or dim white light, or a combination thereof, selectable by the user, for shining on the user's face and eyes. The device can be used for the treatment of light deficiency disorders or conditions and circadian rhythm disorders and disturbances. 1. A portable head-mounted light therapy device comprising:a strap for securing the device to a user's head; anda light box connected to the strap and comprising one or more light sources selectable by the user and directable to a face or one or more eyes of the user, wherein the one or more light sources provides white light, red light, or a combination thereof, and wherein the one or more light sources are switchable either alone or in combination to provide one or more white lights, one or more red lights, or a combination of white and red lights.2. The device of claim 1 , wherein the one or more light sources are one or more light emitting diodes (LEDs).3. The device of or claim 1 , wherein the white light or red light is bright claim 1 , dim claim 1 , or a combination thereof.4. (canceled)5. The device of claim 1 , wherein the strap is adjustable.6. The device of claim 1 , wherein the light box is pivotable at an angle relative to a substantially vertical plane to direct the one or more light sources at the angle to the user's face.7. The device of claim 6 , wherein the angle is from about −5 to about +20 degrees.8. The device of claim 1 , wherein the light box comprises an actuator for activating or adjusting the one or more light sources.9. The device of claim 8 , wherein the actuator is actuated in one or more positions to select the one or more light sources.10. The device of claim 1 , wherein the red light is configured to about 80 lux at 5 cm claim 1 , and the white light is configured to about 800 lux ...

Methods for Treating Psychiatric Disorders Using Light Energy

Methods for treating psychiatric disorders using light energy are disclosed herein. A method for treating psychiatric disorders using light energy includes determining which hemisphere of the brain requires treatment using lateral visual field stimulation (LVFS) and applying light energy to the hemisphere of the brain to treat the psychiatric disorder other than depression. In an embodiment, light energy may include near infrared light (NIR). The methods of the present disclosure may be used to treat a variety of psychiatric disorders. In an embodiment, the methods may be used to treat a psychiatric disorder co-morbid with depression.

LIGHT THERAPY MODALITY

A method of light therapy includes non-invasive, intra-cranial administration of bright light via the ear canal of a subject by using a light intensity of 0.7-12 lumens, and a treatment time of 1-15 minutes. A medical device including radiation elements for directing the light via the ear canal for use in the light therapy is described. 116-. (canceled)17. A medical device for treating a subject in need of light therapy , the medical device comprising:radiation means for directing light directly into an ear canal of the subject, the radiation means including at least one phosphorus-based white light emitting diode (“LED”) having a primary peak wavelength in the range of 450-475 nm and a secondary peak wavelength in the range of 495-570 nm;adapter means for arranging the radiation means in an external ear of the subject to enable administration of light via the ear canal; anda controller unit for adjusting bright light administration and optical radiation provided to the ear canal by the radiation means.18. The medical device of claim 17 , wherein a power intensity in the primary peak wavelength range is substantially 50% higher than a power intensity in the secondary peak wavelength range.19. The medical device of claim 18 , wherein the power intensity in the primary peak wavelength range is about 1.5 E-04 W/nm and the power intensity in the secondary peak wavelength range is about 1.0 E-04 W/nm.20. The medical device of claim 17 , wherein the radiation means consists of one LED per ear canal of the subject.21. The medical device of claim 20 , wherein each LED is inserted directly into a corresponding ear canal.22. The medical device of claim 17 , wherein the radiation means directs light having an intensity in the range of 3-10 lumens directly into the ear canal of the subject.23. The medical device of claim 17 , wherein the subject is in need of light therapy for prevention of migraine headaches claim 17 , the light therapy is administered once per day claim 17 , ...

SPECTACLES FOR LIGHT THERAPY

The present invention provides for eyeglasses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. 1. An apparatus for administering light therapy , the apparatus comprising:a spectacle frame suitably sized for wearing on a human being and securing one or more optical lenses, wherein the optical lenses comprise a barrier portion capable of directing a therapeutic light away from the optic zone allowing unobstructed vision;one or more light sources fixedly mounted to cause the therapeutic light to scatter over the optical lenses, and wherein the scattering allows for indirect exposure of the eye to the therapeutic light;a control mechanism in electrical communication with the one or more light sources, wherein the control mechanism comprises an electronic circuit capable of controlling the one or more light sources and a processor in electrical communication with the electronic circuit, wherein the processor is capable of generating a programmed light schedule based on predefined parameters; anda power source capable of providing energy to the control mechanism and the one or more light sources.2. The apparatus of wherein the optical lenses further comprise a shield layer capable of limiting observation of the therapeutic light by nonwearers.3. The apparatus of further comprising:a light sensor in electrical communication with the control mechanism, wherein the light sensor is capable of sensing ambient light and wherein the predefined parameters comprise at least an amount of ambient light based on data received from the light sensor.4. The apparatus of claim 1 , wherein the programmed light schedule sets intensity of the therapeutic light claim 1 , duration of indirect exposure claim 1 , pattern of indirect exposure claim 1 , and time of indirect exposure.5. The apparatus of claim 4 , ...

Anti-Depression Light-Wave Device and Usage Thereof

An anti-depression light-wave device includes a switch module, a control module and a light source module, wherein the switch module is connected to a regulatory module by the control module and the regulatory module is connected to the light source module. It provides a voltage of 2.3-2.5V for the light source module. The light produced by the light source is monochromatic light of visible light. Preferable wave range is 590-630 nm of the orange light. Moreover, a light source is provided. The anti-depression light-wave device is used as a device to prevent and treat depression. A significant improvement effect for depression, reduction of side effects of antidepressants is shown.

Optogenetic Control of Reward-Related Behaviors

Provided herein are compositions and methods for disrupting at least one reward-related behavior in an individual through the use of light-responsive opsin proteins used to control the polarization state of the cholinergic interneurons of the nucleus accumbens or the striatum. 1. A non-human animal comprising a light-responsive opsin protein expressed on the cell membrane of a cholinergic interneuron in the nucleus accumbens or the striatum of the animal , wherein the protein is responsive to light and is capable of inducing membrane hyperpolarization of the interneurons when the interneurons are illuminated with the light , wherein the illumination of the protein disrupts at least one reward-related behavior of the animal.2. The non-human animal of claim 1 , wherein the light-responsive opsin protein hyperpolarizes the cell membrane of the cholinergic interneuron.3. The non-human animal of claim 2 , wherein the light-responsive opsin protein is selected from the group consisting of NpHR claim 2 , BR claim 2 , AR claim 2 , and GtR3.4. The non-human animal of claim 3 , wherein NpHR is selected from the group consisting of NpHR2.0 claim 3 , NpHR3.0 claim 3 , and NpHR3.1.5. The non-human animal of claim 1 , wherein the reward-related behavior is drug-related addictive behavior.6. (canceled)7. The non-human animal of claim 4 , wherein the light-responsive opsin protein comprises an amino acid sequence at least 95% identical to the sequence shown in SEQ ID NO:1.8. A brain slice comprising a cross section of the nucleus accumbens or the striatum claim 4 , wherein a light-responsive opsin protein is expressed on the cell membrane of cholinergic interneurons wherein the protein is responsive to light and is capable of inducing membrane hyperpolarization of the interneurons when the interneurons are illuminated with the light claim 4 , wherein the illumination of the protein disrupts reward-related brain function.9. A method for disrupting reward-related behavior in an ...

System, Method, and Applications of Using the Fundamental Code Unit and Brain Language

The present invention relates to a non-invasive system with diagnostic and treatment capacities that use a unified code that is intrinsic to physiological brain function. In an embodiment of the present invention, an approach to the treatment of disorders that supplements existing diagnostic and treatment methods with robust quantitative data analysis are presented. This is achieved by a unification of cognitive and neural phenomena known as the Fundamental Code Unit (FCU), representing identifiable patterns of brain activity at the submolecular, molecular, and cellular levels (intra-brain communications), as well as their manifestations in thought and language (inter-brain communications). 1. A method for affecting living tissue comprising:receiving input from living tissue through at least one read modality;computing at least one signal to effect alterations to the living tissue based on the received input; anddelivering the at least one signal to the living tissue through at least one write modality.2. The method of wherein the at least one read modality comprises: neurotransmitter level and chirality measurement claim 1 , linguistic analysis claim 1 , functional magnetic resonance imaging claim 1 , electroencephalography claim 1 , deep brain stimulation claim 1 , audiovisual stimulation claim 1 , or motion tracking/gait analysis.3. The method of wherein the at least one write modality comprises: protein transduction claim 1 , electrochemical methods of signaling claim 1 , neurotransmitter level and chirality regulation claim 1 , linguistic analysis claim 1 , transcranial magnetic stimulation claim 1 , deep brain stimulation claim 1 , ultrasound signaling claim 1 , audiovisual stimulation claim 1 , photonic pathways inside and outside the brain claim 1 , proton pathways inside and outside the brain.4. The method of wherein the use of photonic pathways inside and outside the brain provides broad regulatory power over neuroplasticity.5. The method of wherein the ...

DEVICE AND METHOD FOR COGNITIVE ENHANCEMENT OF A USER

The present invention relates to a device () and a corresponding method for cognitive enhancement of a user (). For effective cognitive enhancement of the user who is going to execute a cognitive activity the proposed device comprises a light unit () for providing an imperceptible light stimulation to the user, and a control unit () for controlling said light unit () to provide said imperceptible light stimulation less than 5 second before the execution of a cognitive activity by the user. 1303030. Device ( , ′ , ″) for cognitive enhancement of a user comprising:{'b': '31', 'a light unit () for providing an imperceptible light stimulation to the user, and'}{'b': 32', '31, 'a control unit () for controlling said light unit () to provide said imperceptible light stimulation less than 5 second before the execution of a cognitive activity by the user.'}2303030. Device ( claim 1 , ′ claim 1 , ″) as claimed in claim 1 ,{'b': 32', '31, 'wherein said control unit () is adapted to control said light unit () to provide said imperceptible light stimulation less than 1 second, in particular less than 0.5 seconds, before the execution of a cognitive activity by the user.'}3303030. Device ( claim 1 , ′ claim 1 , ″) as claimed in claim 1 ,{'b': 32', '31, 'wherein said control unit () is adapted to control said light unit () to provide an imperceptible patterned light stimulation including a oscillatory pattern.'}4303030. Device ( claim 1 , ′ claim 1 , ″) as claimed in claim 1 ,{'b': 32', '31, 'wherein said control unit () is adapted to control frequency, color, intensity, duration, luminance, hue and/or saturation of the imperceptible light stimulation by said light unit ().'}5303030. Device ( claim 1 , ′ claim 1 , ″) as claimed in claim 1 ,{'b': 32', '31, 'wherein said control unit () is adapted to control said light unit () to provide an imperceptible light stimulation having a frequency in the range from 25 to 200 Hz, in particular in the range from 40 to 80 Hz'}6303030. Device ...

Portable phototherapy device

Disclosed is a portable phototherapy device capable of emitting electromagnetic radiation of a wavelength and intensity sufficient to obtain a desired phototherapeutic effect to a subject, without being in direct physical contact with said subject. The device is portable, capable of being flattened, folded, rolled, compressed, or otherwise collapsed, to a size smaller than that of its operating size. The device may be of any size or shape, and may optionally comprise a frame support. The device may be powered by a variety of sources, including one or more batteries. The device may be configured to deliver electromagnetic radiation sufficient to obtain one or more of a variety of desired phototherapeutic effects.

LOW LEVEL LASER THERAPY FOR ALZHEIMER'S DISEASE

Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade β-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe. 1. An apparatus for administration of biostimulatory phototherapy radiation to a bone of a subject , the apparatus comprising:a transparent output interface,an appliance adapted to hold the output interface into contact with a skin surface overlying the bone or into contact with the bone; anda source of coherent light, which is configured to emit the radiation through the output interface so as to irradiate marrow of the bone at a sufficient intensity to improve brain function when the source of coherent light avoids irradiating a brain of the subject.2. The apparatus according to claim 1 , wherein the coherent light has a wavelength between 630-910 nm.3. (canceled)4. The apparatus according to claim 1 , wherein the source of coherent light is configured to emit the radiation at an intensity sufficient to engender removal of β-amyloid from the brain of the subject.5. The apparatus according to claim 1 , wherein the source of coherent light is a laser.69-. (canceled)10. The apparatus according to claim 1 , wherein the output interface has multiple openings comprising circumferentially oriented or longitudinally oriented slots.11. (canceled)12. The apparatus according to claim 1 , wherein the source of coherent light comprises multiple laser probes that emit the radiation to the marrow simultaneously.1314-. (canceled)15. The apparatus according to claim 1 , wherein the output interface has an axis and a circumference about the axis claim 1 , the output interface comprising fiberoptic elements produce a light radiation directed ...

Personalized lighting control

A lighting system for initiating change in a mammal's circadian or well-being state includes a computational unit configured to receive state information regarding the mammal's circadian or well-being state, and operational information from a light sensor with spectral and luminosity sensitivity. The computational unit is configured to compare the operational information with the state information, and on the basis of this comparison, the computational unit outputs a control signal to a light control unit which, in turn, adjusts a controllable light source to vary its light output so as to initiate the desired change in the mammal's circadian or well-being state.

Control and Characterization of Psychotic States

Provided herein are methods of inducing psychosis in animals using light-responsive opsins and methods of identifying or screening compounds that may be useful in treating psychosis. 1. A non-human animal comprising a light-responsive opsin expressed on the cell membrane of a subset of layer V pyramidal neurons in the prefrontal cortex , wherein light activation of the opsin induces depolarization of the membrane and induces psychosis of the animal.2. The animal of claim 1 , wherein the subset of layer V pyramidal neurons have a single large apical dendrite.3. The animal of claim 1 , wherein the opsin is selected from the group consisting of ChR2 claim 1 , VChR1 claim 1 , and DChR.4. (canceled)5. A prefrontal cortex tissue slice comprising a subset of layer V pyramidal neurons claim 1 , wherein a light-responsive opsin is expressed on the cell membrane of the apical dendrites in layer V pyramidal neurons claim 1 , and wherein light activation of the opsin induces depolarization of the membrane.6. The prefrontal cortex tissue slice of claim 5 , wherein the subset of layer V pyramidal neurons have a single large apical dendrite.7. The prefrontal cortex tissue slice of claim 5 , wherein the opsin is selected from the group consisting of ChR2 claim 5 , VChR1 claim 5 , and DChR.8. The prefrontal cortex tissue of claim 5 , wherein the opsin is selected from the group consisting of SFO claim 5 , SSFO claim 5 , C1V1 claim 5 , C1V1-E122T claim 5 , C1V1-E162T claim 5 , and C1V1-E122T/E162T.9. A method of inducing psychosis in a non-human animal claim 5 , comprising activating a light-responsive opsin by light claim 5 , wherein the light-responsive opsin is expressed on the cell membrane of a subset of layer V pyramidal neurons in the prefrontal cortex in the animal claim 5 , and wherein the light activation of the opsin induces depolarization of the cell membrane.10. The method of claim 9 , wherein the subset of layer V pyramidal neurons have a single large apical dendrite.11 ...

USING LIGHT TO REGULATE UTERINE CONTRACTIONS

Methods of regulating uterine contractions using light are described. An exemplary method of regulating uterine contractions comprises suppressing a nocturnal endogenous melatonin level of a pregnant female experiencing uterine contractions by exposing the pregnant female during nighttime to a light source emitting visible light. 1. A method of regulating uterine contractions , the method comprising suppressing a nocturnal endogenous melatonin level of a pregnant female experiencing uterine contractions by exposing the pregnant female during nighttime to a light source emitting visible light.2. The method of claim 1 , wherein the light source intensity is about 10 claim 1 ,000 lux.31. The method of claim 1 , wherein the light source intensity is about 10 claim 1 ,000 lux and the light source is positioned about meter from the eyes.4. The method of claim 1 , wherein exposure to the light source occurs between 9 p.m. to 6 a.m.5. The method of claim 1 , wherein the light source predominantly emits blue light.6. A method of regulating uterine contractions in a pregnant female claim 1 , the method comprising selecting a pregnant female experiencing uterine contractions claim 1 , directing light from a light source emitting visible light onto the pregnant females eyes at night claim 1 , the intensity of the visible light being sufficient to suppress the pregnant female's endogenous melatonin level.7. The method of claim 6 , wherein the intensity is about 10 claim 6 ,000 lux.8. The method of claim 6 , wherein the intensity is about 10 claim 6 ,000 lux and the light source is positioned about 1 meter from the eyes.9. The method of claim 6 , wherein exposure to the light source occurs between 9 p.m. to 6 a.m.10. The method of claim 6 , wherein the light source predominantly emits blue light.11. A method of regulating nocturnal uterine contractions during preterm labor claim 6 , the method comprising exposing a pregnant female experiencing preterm labor to a light source at ...

Neurologic therapy devices, systems, and methods

A neurologic therapy device that is useful for rehabilitating patients suffering from one or more speech, and methods using the same. In embodiments the neurologic therapy device includes a band, one or more actuators on or within the band, and a control system. The control system is configured to cause the actuators to produce stimuli in accordance with a stimulus pattern. When applied to a body part (e.g. stimulus locations) of a user, the stimuli may assist the user to overcome or reduce one or more symptoms of a neurologic disorder. For example, the stimuli may assist an aphasia patient to initiate and/or cadence his/her speech.

METHODS AND SYSTEMS FOR DIAGNOSING AND TREATING EYES USING LIGHT THERAPY

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects. 1. (canceled)2. A wearable augmented reality device comprising: a frame configured to be worn on the head of a wearer wearing the head-mounted ophthalmic system;', pass light from the world into an eye of; and', 'output light from the light source into the eye of the wearer to form an image in the eye,, 'an augmented reality display attached to the frame and comprising a light source, the display configured to], 'an augmented reality head-mounted ophthalmic system comprising detect an amount of one or more wavelengths of light propagating towards the eye; and', 'modify the amount of the one or wavelengths of light reaching the eye based on the detected amount., 'wherein the wearable augmented reality device is configured to3. The device of claim 2 , wherein the head-mounted ophthalmic system is configured to modify the amount of the one or wavelengths of light based on one or more of a time of day claim 2 , a date claim 2 , a time of year claim 2 , or a season.4. The device of claim 3 , wherein the head-mounted ophthalmic system is configured to modify an amount of blue light reaching the eye depending on temporal proximity to a sleep time of the wearer.5. The device of claim 3 , wherein the one or wavelengths of light comprise wavelengths of light corresponding to the color blue.6. The device of claim 2 , wherein the head-mounted ophthalmic system is configured to:block at least a portion of the wearer's view of the world, thereby reducing the amount of the one or more ...

Methods and systems for neural stimulation via visual stimulation

Systems and methods of the present disclosure are directed to systems and methods for treating cognitive dysfunction in a subject in need thereof. The system can include eyeglasses, a photodiode positioned to detect ambient light, light sources, and an input device. The system can include a neural stimulation system that retrieves a profile and selects a light pattern having a fixed parameter and a variable parameter. The neural stimulation system can set a value of the variable parameter of the light pattern, construct an output signal, and then provide the output signal to the light sources to direct light towards the fovea.

Augmented and virtual reality display systems and methods for delivery of medication to eyes

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects.

AUGMENTED AND VIRTUAL REALITY DISPLAY PLATFORMS AND METHODS FOR DELIVERING HEALTH TREATMENTS TO A USER

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects. 1. (canceled)2. A wearable augmented reality device configured to be used by a wearer , the device comprising: a frame configured to be worn on the head of a wearer wearing the head-mounted ophthalmic system;', pass light from the world into an eye of; and', 'output light from the light source into the eye of the wearer to form an image in the eye,, 'an augmented reality display attached to the frame and comprising a light source, the display configured to], 'an augmented reality head-mounted ophthalmic system comprisingwherein the augmented reality head-mounted ophthalmic system is configured to deliver therapy a therapy to the wearer, wherein the therapy is selected from the group consisting of tactile therapy, sound therapy, and temperature therapy.3. The device of claim 2 , wherein the ophthalmic system is configured to massage the face or skull of the wearer.4. The device of claim 3 , wherein the ophthalmic system further comprises an actuator having a contact surface configured to contact the wearer during the massage.5. The device of claim 4 , wherein the actuator is selected from the group consisting of piezoelectric actuators claim 4 , eccentric cams claim 4 , Eccentric Rotating Mass (ERM) vibration motors claim 4 , and Linear Resonant Actuators (LNAs).6. The device of claim 2 , wherein the augmented reality head-mounted ophthalmic system further comprises speakers configured to deliver the sound therapy.7. The device of claim 6 , wherein the augmented reality head- ...

METHODS AND SYSTEMS FOR DIAGNOSING AND TREATING EYES USING LASER THERAPY

Configurations are disclosed for a health system to be used in various healthcare applications, e.g., for patient diagnostics, monitoring, and/or therapy. The health system may comprise a light generation module to transmit light or an image to a user, one or more sensors to detect a physiological parameter of the user's body, including their eyes, and processing circuitry to analyze an input received in response to the presented images to determine one or more health conditions or defects. 1. (canceled)2. A wearable augmented reality device comprising: a frame configured to be worn on the head of a wearer wearing the head-mounted system; and', 'a display attached to the frame, the display configured to pass light from the world into an eye of the wearer; and, 'an augmented reality head-mounted ophthalmic system comprising an augmented reality display platform comprisinga laser configured to administer laser therapy to the eye of the wearer.3. The device of claim 2 , wherein the laser is mounted to the frame.4. The device of claim 2 , wherein the augmented reality head-mounted ophthalmic system is configured to display images to the wearer as part of the laser therapy.5. The device of claim 4 , wherein the augmented reality head-mounted ophthalmic system is configured to orient the eye of the wearer in a desired direction during exposing the wearer to light from the laser claim 4 , wherein the augmented reality head-mounted ophthalmic system is configured to orient the eye by displaying an object for the eye of the wearer to focus on.6. The device of claim 4 , wherein the augmented reality head-mounted ophthalmic system is configured to display a moving object as part of the laser therapy.7. The device of claim 2 , wherein the augmented reality head-mounted ophthalmic system is configured to provide instructions to the wearer before exposing the wearer to light from the laser.8. The device of claim 7 , wherein the augmented reality head-mounted ophthalmic system is ...

METHODS AND DEVICES FOR VISIBLE LIGHT MODULATION OF MITOCHONDRIAL FUNCTION IN HYPOXIA AND DISEASE

The present invention provides methods of using electromagnetic radiation in the visible portion of the spectrum to modulate mitochondrial function in the treatment of various conditions, including Alzheimer's disease, other demential, hypoxia and diabetic peripheral neuropathy, and sensory disorders of the extremities. 1. A medical treatment device , comprising:a patch wearable by a mammal, the patch having a tissue facing surface and including a light source operable to emit outwardly from the tissue facing surface electromagnetic radiation in a visible portion of the electromagnetic spectrum from about 375 nm to 625 nm, the electromagnetic radiation being substantially free of electromagnetic radiation in the portion of the electromagnetic spectrum between 650 nm and 700 nm.2. The device of claim 1 , wherein the light source is operable to emit the electromagnetic radiation in the visible portion of the electromagnetic spectrum with at least one of a surface power density of about 10 mW/cmto about 10 W/cmor a total power output of about 25 mW to about 100 W measured adjacent to the tissue facing surface.3. The device of claim 1 , wherein the tissue facing surface of the patch has a surface area of from about one square inch to about ten square inches.4. The device of claim 3 , wherein the patch is conformable to a neck of a human.5. The device of claim 1 , wherein the tissue facing surface of the patch has a diameter of about 0.5 to about 4.0 inches.6. The device of claim 1 , further comprising:a biocompatible adhesive carried by the patch to selectively removably attach the patch to a bodily tissue of the mammal.7. The device of claim 1 , further comprising:a battery integral to the patch and electrically coupled to supply electrical power to the light source.8. The device of claim 7 , wherein the battery is sized to provide only a single-use treatment.9. The device of claim 1 , further comprising:a controller coupled to selectively control the light source.10. ...

Novel Treatment Methodologies Using Light Therapy

An exemplary method of treatment involves the non-invasive delivery of near infrared light (NIR) in 600-1200 nm wavelengths at surface wattage of 10.01-20.00 watts applied using a continuous motion technique. Treatment duration can be 30-1800 seconds, and can be conducted using a specific pulsed NIR technique for minimizing surface tissue heating. This is a novel process of non-invasive NIR/laser therapy. Prior applications used low levels of NIR therapy—most less than 1 watt with some up to 5 watts. Embodiments of the methodologies can be practiced with a laser unit having control for wavelength and for 1-20 watts. A Pulsed (on/off laser beam) control for 1-1000 milliseconds may also be utilized. An applicator with 1-2 cm aperture can be used to produce approximately 0.64-1.95 Joules per cm2 fluence in the depth of tissue. A display detailing watts, time, continuous or pulsing, and Joules of therapy is useful. 1. A method of novel treatment using light therapy to treat at least one of a set of conditions including Traumatic Brain Injury , Idiopathic Parkinson's Disease , Alzheimer's Disease , Senility , Dementia , Post-Traumatic Stress Disorder , Depression , and Anxiety , the method comprising:readying a patient for treatment by ensuring patient has at least one of the set of conditions and has no allergy to infrared light;preparation and positioning the patient by ensuring that an area to be treated has no lotions and no oils present, that any hair present is cut short, and that the area to be treated is made fully accessible;enhancing safety by ensuring that patient and operator wear safety gear;configuring a system by setting a laser control and interface unit to appropriate specifications for a given condition and patient, which includes specifying a plurality of wavelengths between 600 and 1200 nanometers, specifying a plurality of wattages between 10.01 and 20.00 watts, and specifying whether a laser will pulse and details of any pulses;activating applicator ...

SMART RELAXATION MASKS WITH WIRED EARPIECES

A relaxation mask includes: a main body that defines a pair of eye cavities; wiring; an earpiece that is coupled to the main body via the wiring; and a spring configured to bias the earpiece towards the main body. 1. A relaxation mask comprising:a main body defining a pair of eye cavities;wiring;an earpiece coupled to the main body via the wiring; anda spring configured to bias the earpiece towards the main body.2. The relaxation mask of claim 1 , wherein the wiring defines the spring.3. The relaxation mask of claim 2 , wherein the wiring includes a serpentine segment that defines the spring.4. The relaxation mask of claim 3 , further comprising:an electronics enclosure;a light diffuser disposed within a first one of the cavities; anda coupling member coupling the light diffuser to the electronics enclosure,wherein the coupling member defines a channel, andwherein the serpentine section is disposed within the channel.5. The relaxation mask of claim 1 , further comprising a sleeve having a first open end and a second open end claim 1 , wherein the wiring passes through the sleeve claim 1 , wherein the sleeve is arranged to overlie a subject's temple region when the relaxation mask is worn.6. The relaxation mask of claim 5 , wherein a high friction material is disposed on an inner surface of the sleeve and is arranged to inhibit movement of the wiring when the relaxation mask is worn.7. The relaxation mask of claim 6 , wherein the wiring includes a first round section arranged at the interface with the earpiece claim 6 , and wherein the wiring includes a flat section that extends through the sleeve.8. The relaxation mask of claim 1 , further comprising an electronics enclosure supported by the main body claim 1 , wherein a first end of the wiring is coupled to the electronics enclosure and a second end of the wiring is coupled to the earpiece.9. The relaxation mask of claim 8 , wherein the wiring includes a first round section arranged at the first end claim 8 , a ...

LIGHT DIFFUSERS FOR SMART RELAXATION MASKS

A relaxation mask includes: a main body that defines a pair of eye cavities; and a light diffuser. The light diffuser includes a first lens that is disposed within a first one of the eye cavities. A first ledge is disposed along a top edge of the first lens and extends outwardly therefrom. A first light emitting component is supported on the first ledge and is configured to fire downward into the first lens. 1. A relaxation mask comprising:a main body defining a pair of eye cavities; and a first lens disposed within a first one of the eye cavities;', 'a first ledge disposed along a top edge of the first lens and extending outwardly therefrom; and', 'a first light emitting component supported on the first ledge and configured to fire downward into the first lens., 'a light diffuser comprising2. The relaxation mask of claim 1 , wherein the light diffuser is molded from a silicone.3. The relaxation mask of claim 2 , wherein the silicone comprises a diffusive additive.4. The relaxation mask of claim 3 , wherein the silicone includes 1% to 30% of the additive by volume.5. The relaxation mask of claim 4 , wherein the silicone includes 15% to 30% of the additive by volume.6. The relaxation mask of claim 1 , further comprising:an electronics enclosure; anda coupling member coupling the light diffuser to the electronics enclosure.7. The relaxation mask of claim 6 , wherein the light diffuser defines a first attachment point and the coupling member defines a second attachment point that is configured to mate with the first attachment point claim 6 , thereby to mechanically couple the light diffuser to the coupling member.8. The relaxation mask of claim 7 , wherein the first and second attachment points comprises a slot and a protrusion configured to engage the slot claim 7 , thereby to mechanically couple the light diffuser to the coupling member.9. The relaxation mask of claim 6 , further comprising:an earpiece; andwiring coupling the earpiece to the electronics enclosure, ...

METHOD FOR INHIBITING MELATONIN SECRETION AND ILLUMINATION DEVICE SUITABLE FOR BEING APPLIED IN LIGHT THERAPY FOR TREATING SEASONAL AFFECTIVE DISORDER

Disclosures of the present invention describe a method for inhibiting melatonin secretion. In the present invention, an illumination device is particularly configured for emitting an illumination light with a specific wavelength that is in a range between 581 nm and 590 nm, and a variety of experimental data have proved that the illumination light functions as a melatonin secretion inhibitor. Therefore, the illumination device of the present invention is evidenced to be suitable for use in light therapy, so as to treat seasonal affective disorder (SAD) by way of inhibiting melatonin secretion. Briefly speaking, after a SAD patient receives the irradiation of the illumination light having wavelength ranged in 581-590 nm for a treatment course, the SAD patient is eventually leaded to stay in good spirits and a stable condition of emotion, thereby curing the abnormal symptoms of sleepiness and emotional disorder. 1. A method for inhibiting melatonin secretion , comprising following steps:providing a light source comprising a first lighting unit, wherein the first lighting unit is configured for emitting a first light with a first wavelength in a range between 581 nm and 590 nm;controlling the light source to emit an illumination comprising the first light; andletting the illumination light function as an melatonin secretion inhibitor by guiding the illumination light to irradiate a seasonal affective disorder (SAD) patient.2. The method of claim 1 , wherein the light source further comprises:a second lighting unit for emitting a second light with a second wavelength in a range between 450 nm and 580 nm; anda third lighting unit for emitting a third light with a third wavelength in a range between 591 nm and 600 nm;wherein the illumination light provided by the light source consists of the first light, the second light and the third light, and having a maximum color temperature of 1500K.3. The method of claim 1 , wherein the first lighting unit is further configured to ...

METHOD OF TREATING MULTIPLE SCLEROSIS

A method and computer program product for suppressing the symptoms of multiple sclerosis (MS) by irradiating a subject exhibiting the symptoms with a pre-determined dose of UV-containing light from a light source and detecting a suppression of the clinical symptoms of MS. In particular, the detected suppression of the clinical symptoms is disassociated from the vitamin D production within the subject. 2. A method according to claim 1 , further comprising identifying the subject with the use of pre-defined diagnostic criteria.3. A method according to claim 1 , wherein the suppression of the clinical symptoms includes at least one of a delay of onset of MS symptoms claim 1 , a reduction of peak of severity of MS symptoms claim 1 , and a decrease of the cumulative disease index (CDI).4. A method according to claim 1 , wherein the method additionally comprises a second light dose.5. A method according to claim 1 , wherein the irradiating includes repeatedly irradiating with such a dose and at such repetition time intervals as to suppress clinical symptoms and wherein the subject does not develop hypercalcemia.6. A method according to claim 1 , additionally comprising the step of irradiating the subject with a second dose of light claim 1 , wherein each of the first and second doses of light comprises a UV irradiance of at least 2.5 kJ/m.7. A method according to claim 1 , wherein the subject is has a reference level of serum calcium and a reference level of a serum 25(OH)D3 claim 1 , and wherein the irradiating the subject includesa) irradiating the subject with a first dose of light from a light source, the first dose being adapted to cause a change of a serum 25(OH)D3 level from the reference level of a serum 25(OH)D3 to a first level that is lower than a threshold level associated with suppression of the clinical symptoms; andb) repeatedly irradiating the subject at repetition time intervals with a second dose of light from the light source, the second dose and ...

MULTI-FUNCTIONAL LIGHTING FIXTURE

A lighting fixture includes a first compartment including a light sealed air plenum and a first lighting source arranged in the plenum to irradiate passing air through the plenum to destroy pathogens. A second compartment is configured to be external to the first compartment. A second lighting source is arranged in the second compartment to illuminate an area adjacent to the second compartment. 1. A lighting fixture , comprising:a first compartment including a light sealed air plenum;a first lighting source arranged in the plenum to irradiate passing air through the plenum to destroy biological material in the air;a second compartment configured to be external to the first compartment; anda second lighting source arranged in the second compartment to illuminate an area adjacent to the second compartment.2. The lighting fixture as recited in claim 1 , wherein the first compartment includes ultraviolet light emitting diodes.3. The lighting fixture as recited in claim 2 , wherein the first compartment includes light containing baffles.4. The lighting fixture as recited in claim 1 , wherein air is forced through the first compartment using a fan.5. The lighting fixture as recited in claim 1 , wherein the first compartment includes a negative ion generator.6. The lighting fixture as recited in claim 1 , wherein the second lighting source includes a configurable array of lights that provide color for one or more of setting a mood claim 1 , providing therapy and promoting healing.7. The lighting fixture as recited in claim 1 , further comprising a backup battery and a backup light for use in power outages.8. The lighting fixture as recited in claim 1 , further comprising a radio frequency identification chip mounted on the fixture to permit remote identification of the fixture.9. The lighting fixture as recited in claim 1 , wherein the fixture fits into a standard light bay.10. The lighting fixture as recited in claim 1 , further comprising a remote control to remotely ...

Light exposure monitoring system

The present disclosure relates to a light exposure monitoring system that includes a central control server; a plurality of indoor light exposure zones and a positioning system configured to communicate with the central control server to determine: a position (P) of an individual within the plurality of indoor light exposure zones, and a distance between a head of the individual and a floor within the plurality of indoor light exposure zones.

Enhanced treatment of brain disorders utilizing coordinated negative suppressive stimulation and related devices designed to achieve treatment

The present invention is directed to enhanced methods of treating brain disorders, and devices suitable to implement these methods. In particular, the methods of treatment and related devices of the present invention utilize the coordinated application of negative suppressive stimulation of the brain hemisphere with the more negative valence in combination with transcranially applied light energy to the lateral forehead to activate the underlying cortex of the brain hemisphere with the more positive valence, e.g., synergistically. In addition, such methods and devices may be suitable to address co-morbid brain disorders (e.g., psychiatric disorder co-morbid with depression) in a more effective manner.

METHODS, APPARATUSES AND SYSTEMS FOR DIAGNOSIS AND TREATMENT OF MOOD DISORDERS

A method and apparatus for diagnosing and/or treating mood disorders, such as depression, is provided. Right vestibular function in subjects diagnosed with a mood disorder is diminished compared with subjects who do not have a mood disorder. Accordingly, a method and apparatus for determining right vestibular function in a subject is provided, from which a diagnosis of a mood disorder may be determined. Stimulation of the vestibular system of a subject diagnosed with a mood disorder may reduce symptoms of the mood disorder in the subject. A method and apparatus for registering a subject's response to stimulation of the vestibular system and providing therapeutic vestibular stimulation based on the subject's response is provided. A subject's response to stimulation of the vestibular system may be based on measurements of nystagmus in the subject. 1105-. (canceled)106. A method of treating a mood disorder in a subject , the method comprising:(a) applying diagnostic vestibular stimulation to a subject;(b) registering the subject's response to the diagnostic vestibular stimulation, said registering comprising measuring an asymmetry between a right side of the subject's vestibular system and a left side of the subject's vestibular system; and(c) treating the mood disorder in the subject by applying therapeutic vestibular stimulation to the subject using at least one apparatus, the therapeutic vestibular stimulation determined using at least one processor based on the asymmetry measured in response to the diagnostic vestibular stimulation,wherein the therapeutic vestibular stimulation is configured to stimulate the left side of the subject's vestibular system and the right side of the subject's vestibular system in a different manner, andwherein the different manner between said stimulation of the left side of the subject's vestibular system and the right side of the subject's vestibular system is determined, by the at least one processor, based on the registered response ...

OPTOGENETIC CONTROL OF ENDOTHELIAL CELLS

The invention features methods for regulating vascular properties by controlling the membrane properties of endothelial cells using optogenetics and light. The invention features methods to transport therapeutics across the vascular barrier into tissues such as the brain and the lung, with high spatial and temporal precision, and for controlling vascular properties such as vascular tone, arterial diameter, and vascular growth. 12-. (canceled)3. A method to deliver a therapeutic across the vascular endothelial barrier comprising endothelial cells expressing an optogenetic reagent in a subject , said method comprising the steps of: a) introducing said therapeutic into the blood stream of said subject; and b) contacting said endothelial cells with light , wherein said light activates said optogenetic reagent and thereby changes permeability of said endothelial cells and opens the vascular endothelial barrier such that said therapeutic in the blood stream crosses the vascular endothelial barrier.4. The method of claim 3 , wherein said optogenetic reagent is selected from the group consisting of ChR1 claim 3 , ChR2 claim 3 , VChR1 claim 3 , ChR2 C128A claim 3 , ChR2 C128S claim 3 , ChR2 C128T claim 3 , ChD claim 3 , ChEF claim 3 , ChF claim 3 , ChIEF claim 3 , NpHR claim 3 , eNpHR claim 3 , Arch 3.0 claim 3 , Arch T 3.0 claim 3 , Mac 3.0 claim 3 , melanopsin claim 3 , chimeras of these proteins and natural and engineered variants thereof.5. The method of claim 3 , wherein said optogenetic reagent are expressed in the endothelial cells by introducing a recombinant nucleic acid encoding the optogenetic reagent into said cells or precursors thereof.6. The method of claim 5 , wherein said recombinant nucleic acid is introduced into said cells by using any one or more of a virus claim 5 , an electroporation device claim 5 , a transfection method claim 5 , and a transgenic method.7. The method of claim 6 , wherein said recombinant nucleic acid is encapsidated within a ...

LIGHT THERAPY GLASSES AND MOBILE APPLICATION

A portable light therapy device configured to be worn by a patient proximate the eyes includes a front frame including a pair of eye frame sections coupled to each other by a bridge. The bridge is supported on a nose of a patient when worn such that each eye frame section is positioned in front of a respective eye of the patient. A pair of side frames is coupled to opposing ends of the front frame such that, when the device is worn, the side frames extend generally perpendicularly to a plane defined by the front frame. A pair of light modules are each attached to a respective one of the side frames. Each light module includes a light source that emits light and a battery that provides power to the light source, wherein light emitted by each light source is directed into a respective eye of the patient. 1. A portable light therapy device configured to be worn by a patient proximate eyes of the patient , the device comprising:a front frame including a pair of eye frame sections coupled to each other by a bridge, the bridge being configured to be supported on a nose of a patient when worn such that each of the eye frame sections is positioned in front of a respective eye of the patient;a pair of side frames coupled to opposing ends of the front frame such that, when the device is worn by the patient, the side frames extend generally perpendicularly to a plane defined by the front frame; anda pair of light modules, each of which is attached to a respective one of the side frames, each light module including a light source configured to emit light and a battery configured to provide power to the light source, wherein light emitted by each light source is directed into a respective eye of the patient.2. The portable light therapy device of claim 1 , further comprising a pair of reflectors claim 1 , each mounted on a respective one of the side frames proximate the respective light source claim 1 , wherein the reflector is configured to direct light emitted by the ...

Light Therapy Monitoring

A light-monitoring apparatus includes a power source, a light detector, a computer processor coupled with the power source and in communication with the light detector and configured to receive and record light exposure detected by the light detector, an output device coupled with the computer processor, and a computer-readable medium coupled with the computer processor and storing instruction code for summing the recorded light exposure from the computer processor over time and communicating a signal to the output device to generate and communicate a signal indicating that a cumulative threshold light exposure for achieving a health benefit has been reached. The apparatus can accordingly be used by an individual to monitor cumulative light exposure from both natural and artificial sources, e.g., in the treatment of seasonal or non-seasonal depression.

SYSTEMS AND METHODS OF DYNAMIC ILLUMINATION AND TEMPORALLY COORDINATED SPECTRAL CONTROL AND BIOLOGICAL DIMMING

Lighting systems and methods for providing biologically optimized illumination throughout the day are disclosed. Systems and methods of providing LED light engines and associated illumination spectrums that are both visually appealing, rich in melanopic flux and that reduce blue light hazard exposure are disclosed. Embodiments of the invention relating to specific spectra of illumination containing high or low amounts of melanopic light, spectrally and spatially tunable LED lighting systems, programmed and automated controllers for temporally controlling bio-effective illumination, and dimming circuitry for tuning the spectral output of lighting devices are also disclosed. 120.-. (canceled)21. A method of facilitating circadian rhythm regulation , the method comprising:providing a light engine, wherein the light engine comprises i) a first LED module that emits white light, ii) a second LED module that emits light having a first peak emission intensity between 470 nm and 490 nm and a second peak emission intensity centered on 660 nm, and iii) a third LED module that emits a narrow band illumination in a wavelength band between 410 nm and 430 nm, wherein the light from the second LED module and the third LED module are emitted in an upward direction;adjusting a current flow to the second LED module such that an intensity of the light emitted between 470 nm to 490 nm is increased toward a daily maximum level during a first portion of a photoperiod, thereby providing illumination rich in melanopic light during a second portion of the photoperiod;adjusting the current flow to the second LED module such that the intensity of the light emitted between 470 nm to 490 nm is decreased during a third portion of the photoperiod, thereby providing illumination depleted in melanopic light during a fourth portion of the photoperiod; andadjusting a current flow to the third LED module such that the narrow band illumination is generated for a time period not exceeding 60 minutes ...

Apparatus For Correcting Circadian Rhythm And Method Thereof

The present disclosure provides a circadian rhythm correcting apparatus including a bio-illuminance measuring part configured to measure bio-illuminance of external light, a light source configured to irradiate light of a circadian wavelength band toward a retinal ganglion cell, a light source driver configured to drive the light source by supplying power to the light source, and a controller configured to control the light source driver on the basis of the bio-illuminance measured by the bio-illuminance measuring part, to correct the circadian rhythm. 1. A circadian rhythm correcting apparatus comprising:a bio-illuminance measuring part configured to measure bio-illuminance of external light;a light source configured to irradiate light of a circadian wavelength band toward a ganglion cell;a light source driver configured to drive the light source by supplying power to the light source; anda controller configured to control the light source driver on the basis of the bio-illuminance measured by the bio-illuminance measuring part.2. The circadian illuminance correcting apparatus of claim 1 , wherein the controller compares the bio-illuminance with reference bio-illuminance and drives the light source driver when the bio-illuminance is lower than the reference bio-illuminance.3. The circadian illuminance correcting apparatus of claim 1 , wherein the controller compares the bio-illuminance with reference bio-illuminance and outputs a control signal corresponding to a value of a difference between the bio-illuminance and the reference bio-illuminance to the light source driver.4. The circadian illuminance correcting apparatus of claim 3 , wherein the light source driver adjusts an amount or application time of the power supplied to the light source on the basis of the control signal.5. The circadian illuminance correcting apparatus of claim 2 , wherein the reference bio-illuminance is an illuminance value required to maintain a regular circadian rhythm claim 2 , and ...

Device and method for treatment of tinnitus

A device for the therapeutic treatment of tinnitus is disclosed, wherein a device for treatment of tinnitus comprising a topographic geometrical matrix and a support, wherein each topographic geometrical matrix is applied to the support and comprising a) at least two concentric circles, b) a circle having at least one circle inscribed, wherein said circle and said at least one circle have a common tangential arc point; wherein for both a) and b) above the innermost circle is open or closed, the diameter of the outermost circle is at most 130 mm, and the diameter of the innermost circle is at most 3 mm, and wherein the ratio between the diameter of the outermost circle and the diameter of the next circle counted inwards toward the common center of the circles is at least 1.3; and c) a set of identical circles arranged with the basis on the pattern of the flower of life shown in FIG. 2, or asymmetrical variants of a)-c) having the ability to synchronize water according to the synchronization test as defined in Example 1, as well as a method for therapeutic treatment of tinnitus, wherein at least one device as defined above and herein is applied on the body of a tinnitus patient, such as to the skin on the upper half of the body, such as to the head, such as in the vicinity of the affected ear, and is subjected to light with a wavelength of 360-4000 nm, such as daylight.

LED LIGHT CONTROLLER AND METHOD OF CONTROLLING LED LIGHTS

A method controls the light exposure of an individual during a given time period. A control unit is provided for controlling lights. A first sensor is worn by the individual and gathers light exposure data including lighting intensity data and Kelvin temperature data experienced by the individual. Second sensors are disposed in a building for collecting emitted light data emitted in the building. The emitted light data and the light exposure data are transmitted to the control unit. The light data, along with desired data including desired light intensity and desired Kelvin temperature are stored. The optimal light exposure for the individual is determined based on the light data or the desired data, and an output signal is generated based on the optimal light exposure. The lights are controlled based on the output signal to produce an overall light intensity and Kelvin temperature pattern per day for the individual. 1. An LED lighting unit that can be adjusted for both brightness and Kelvin temperature , the LED lighting unit comprising:LED lights for outputting light;a power switch controlling power to said LED lights for turning said LED lights on and off;a light dimming switch for adjusting a power output of said LED lights;a Kelvin temperature changing switch for controlling the Kelvin temperature of said LED lights;a control unit controlling individual and groups of said lights controlled by said power switch, said control unit having a memory;first sensors to be worn by individuals for gathering individual light data including lighting intensity data and Kelvin temperature data experienced by the individuals, said first sensors transmitting the individual light data to said control unit;second sensors to be disposed in a building for collecting building light data including light intensity building data and Kelvin temperature building data and transmitting the building light data to said control unit;said memory unit of said control unit storing the ...

Lighting apparatus with optimum stimulation of non-visual functions

The lighting equipment comprises a lighting device with a plurality of light sources for delivering white light having a tunable light spectrum, and a monitoring and control device that controls the light sources in a modulation cycle for modulating the light spectrum, which cycle comprises a first period where the light spectrum is red-enriched, a second period where the light spectrum is gradually modulated from red to blue, a third period where the light spectrum is blue-enriched, and a fourth period where the light spectrum is modulated gradually from blue to red. The control device is arranged to detect reception of a signal indicating a human presence, and, in response, reinitializes the modulation cycle when the modulation cycle is in the first period, or gradually modulates the light spectrum from blue to red when the modulation cycle is in the second, third or fourth period before reinitializing the modulation cycle.

LIGHTING SYSTEM FOR PROTECTING CIRCADIAN NEUROENDOCRINE FUNCTION

Lighting systems, methods, and devices for protecting human circadian neuroendocrine function during night use are described. Suitable lighting conditions can be provided for a working environment while protecting the circadian neuroendocrine systems of those occupying the illuminated workplace during the night. Lighting systems, methods, and devices can provide substantive attenuation of the pathologic circadian disruption in night workers. Lighting systems, methods, and devices can attenuate the specific bands of light implicated in circadian disruption. LED lighting systems, methods, and devices can provide increased intensity at a different portion of the spectrum than conventional LEDs, providing a useable white light even when unfavorable portions of the wavelength are attenuated by a notch filter. LED lighting systems, methods, and devices can switch between a daytime configuration and a night time configuration, wherein the daytime configuration provides unfiltered light and the night time configuration provides filtered light. 170-. (canceled)71. An artificial light source , wherein the artificial light source delivers light in the visible light range and provides a Circadian Night Mode (CNight Mode) in which light delivered in a selected bioactive wavelength band range delivers less than six percent (6%) of the total irradiance from the artificial light source in the visible light range; wherein the CNight Mode violet light is provided in a wavelength band selected from a group consisting of: between about 400 and about 440 nm , between about 400 and about 435 nm , between about 400 and about 430 nm , between about 400 and about 425 nm , and between about 400 and about 415 nm , and that has an average irradiance greater than about four percent (4%) , of the total irradiance from the light source in the visible light range.72. The artificial light source of claim 71 , wherein the selected bioactive wavelength band range in the CNight Mode is selected from a ...

Temporally Modulated Multi-LED for Enhanced Subconscious Physiological Responses

A light source and a method of generating a light using the light source is disclosed. The light source is configured to produce a plurality of distinct colors in generating the light, one of the distinct colors falling within a blue spectral light band. A light controller modulates the spectral light produced by the plurality of distinct colors. The modulation provides melanopsin contrast in order to increase melanopsin responsiveness of a subject exposed to the generated light and maintains the color temperature, color quality, and color constancy experienced by the subject in a lit viewing environment within an acceptable range. 1. A method of generating light using a light source , the method comprising:generating lighting signals for controlling the light source, wherein the light source is configured to produce a plurality of distinct colors in generating the light, at least one of the distinct colors falling within a blue spectral light band;modulating the lighting signals to modulate the light produced by the plurality of distinct colors, the modulation being chosen to provide optimal melanopsin contrast in order to increase melanopsin responsiveness of a subject exposed to the light and the modulation being chosen to maintain color temperature and color quality within an acceptable range; andapplying the modulated lighting signals to the light source and generating the light for thereby increasing the melanopsin contrast responsiveness of the subject exposed to the light.2. The method of claim 1 , wherein the light source is an LED light source.3. The method of claim 2 , wherein the LED light source is an LED array comprising a plurality of LEDs.4. The method of claim 2 , wherein the LED light source comprises 4 or more LEDs.5. The method of claim 2 , wherein the LED light source comprises 5 or more LEDs.6. The method of claim 1 , wherein modulating the lighting signals to modulate the light produced by the plurality of distinct colors comprises applying ...

SYSTEMS AND METHODS FOR PREVENTING, MITIGATING, AND/OR TREATING DEMENTIA VIA VISUAL STIMULATION THAT BINDS HIGHER ORDER BRAIN REGIONS, REDUCES NEURODEGENERATION AND NEUROINFLAMMATION, AND IMPROVES COGNITIVE FUNCTION

Devices, systems, and methods for treating dementia or Alzheimer's disease in a subject in need thereof. In one example, chronic visual stimuli having a frequency of about 30 Hz to about 50 Hz, and more specifically about 40 Hz, are non-invasively delivered to the subject to entrain gamma oscillations in multiple brain regions of the subject, including the prefrontal cortex (PFC) and the hippocampus. The entrained gamma oscillations modulate neuronal activity across multiple brain regions (e.g., facilitate functional binding of neural networks at low gamma frequencies) to induce various neuroprotective effects (e.g., amelioration of amyloid plaques and tau hyper-phosphorylation) and reduce neurodegeneration. Neuronal activity mediated by the chronic visual stimuli reduces an immune response in microglia and ameliorates aberrantly modified genes and proteins involved in membrane trafficking, intracellular transport, synaptic function, neuroinflammation and DNA damage response. Behavior modification including enhanced learning and memory is observed. 1. (canceled)2. A method for increasing expression of genes and/or proteins associated with vesicle mediated transport in neurons in a subject for treating dementia or Alzheimer's disease in the subject in need thereof , the method comprising:non-invasively delivering visual stimuli having a frequency of about 30 Hz to about 50 Hz to the subject for at least 6 weeks.3. The method of claim 2 , wherein the visual stimuli have a frequency of about 40 Hz.4. The method of claim 2 , wherein the non-invasively delivering further includes non-invasively delivering the visual stimuli to the subject for at least 1 hour per day.5. The method of claim 2 , wherein the non-invasively delivering further includes increasing expression of one or more genes selected from the group consisting of: vGlut1 claim 2 , Slc1a3 claim 2 , Chmp2a claim 2 , Ank1 claim 2 , Tmed10 claim 2 , Apoe claim 2 , Clu claim 2 , and Myo6.6. The method of claim 2 ...

APPARATUS AND METHOD FOR INHIBITING MELATONIN SYNTHESIS IN A HORSE

An apparatus for inhibiting melatonin synthesis in a horse comprises a blinker having an internal surface of which at least a part is diffusing. A source of light is positioned for direction into the horse's eye by the diffusing-surface. The light source and diffusing surface are configured such that the light directed into the horse's eye is blue. 1. An apparatus for inhibiting melatonin synthesis in a horse , comprising a blinker having an internal surface of which at least a part is diffusing , and a source of light positioned for direction into the horse's eye via the diffusing surface , the light source and diffusing surface being configured such that the light directed into the horse's eye is blue.2. An apparatus according to wherein the internal surface of the blinker claim 1 , which in use faces the horse's eye claim 1 , is generally concave.3. An apparatus according to wherein the light source claim 1 , in use claim 1 , emits blue light and the diffusing surface does not significantly filter the blue light.4. An apparatus according to wherein the blue light has a peak wavelength of from 440 to 490 nm claim 1 , preferably 459 to 484 nm claim 1 , and most preferably 468 nm.5. An apparatus according to wherein the light source has an intensity of from 10 to 100 lux claim 1 , most preferably 10 to 50 lux.6. An apparatus according to wherein the light source comprises at least one LED.7. An apparatus as claimed in wherein said light source comprises an LED with a diffusing surface claim 1 , the LED being located in said blinker to direct light towards the horse's eye.8. An apparatus according to wherein the diffusing surface of the blinker is diffusively reflective.9. An apparatus as claimed in wherein said diffusing surface incorporates one of: a photo luminescent; or a thermo luminescent material.10. An apparatus as claimed in further including a kinetically powered light source.11. An apparatus according to wherein the light source is shielded to ...

Methods For Generating Melatonin-Response-Tuned White Light With High Color Rendering

The present disclosure provides methods for generating tunable white light with controllable circadian energy performance. The methods use a plurality of LED strings to generate light with color points that fall within blue, yellow/green, red, and cyan color ranges, with each LED string being driven with a separately controllable drive current in order to tune the generated light output. Different light emitting modes can be selected that utilize different combinations of the plurality of LED strings in order to tune the generated white light. 1. A method of generating white light , the method comprising:producing light from a first light emitting diode (“LED”) string that comprises a blue LED with peak wavelength of between about 405 nm and about 470 nm;producing light from a second LED string that comprises a blue LED with peak wavelength of between about 405 nm and about 470 nm;producing light from a third LED string that comprises a blue LED with peak wavelength of between about 405 nm and about 470 nm, a fourth LED string that comprises a cyan LED with peak wavelength of between about 485 nm and about 520 nm; andpassing the light produced by each of the first, second, third, and fourth LED strings through one of a plurality of respective luminophoric mediums;wherein the light produced by the second LED string generates a red color point after passing through said one of the plurality of respective luminophoric mediums;wherein spectral power distribution for the red color point includes between 48.5% and 102.8% for wavelengths between 581 nm to 620 nm, 100% for wavelengths between 621 nm to 660 nm, between 1.8% to 74.3% for wavelengths between 661 nm to 700 nm, between 0.5% to 29.5% for wavelengths between 701 nm to 740 nm, and between 0.3% to 9.0% for wavelengths between 741 nm to 780 nm; andcombining the light exiting each of the plurality of respective luminophoric mediums together into the white light;wherein the white light corresponds to at least one of a ...

Methods For Generating Melatonin-Response-Tuned White Light With High Color Rendering

The present disclosure provides methods for generating tunable white light with controllable circadian energy performance. The methods use a plurality of LED strings to generate light with color points that fall within blue, yellow/green, red, and cyan color ranges, with each LED string being driven with a separately controllable drive current in order to tune the generated light output. Different light emitting modes can be selected that utilize different combinations of the plurality of LED strings in order to tune the generated white light. One or more of the LED strings can have ultraviolet or violet LEDs. 1. A method of generating white light , the method comprising:producing light from a first light emitting diode (“LED”) string;producing light from a second LED string;producing light from a third LED string, a fourth LED string, or both the third LED string and the fourth LED string; andpassing the light produced by each of the first, second, third, and fourth LED strings through one of a plurality of respective luminophoric mediums;combining the light exiting the plurality of respective luminophoric mediums together into white light;wherein the combined white light corresponds to at least one of a plurality of points along a predefined path near the black body locus in the 1931 CIE Chromaticity Diagram;wherein one or more of the first, second, third, and fourth LED strings comprises a ultraviolet or violet LED having a peak wavelength of between about 360 nm and about 430 nm;wherein:the light produced from the first LED string is passed through a first recipient luminophoric medium that comprises a first luminescent material, wherein light exiting the first luminophoric medium comprises unsaturated light having a first color point within a blue color range;the light produced from the second LED string is passed through a second recipient luminophoric medium that comprises a second luminescent material, wherein the light exiting the second luminophoric medium ...

Lighting System for Circadian Control and Enhanced Performance

Systems tune, control, or remediate the intrinsic Circadian clock. A light controller sets spectral distribution, intensity of a bioactive spectral band to shift or entrain circadian response to enhance performance and/or synchronize with local or expected conditions. The systems enhance performance under conditions that might be changing, disrupted, or otherwise present an irregular phase or unnatural change in the subject's circadian status, for example, due to geographically discontinuous activity or spectrally deficient workplace illumination, or due to divergent individual sleep/wake behaviors of subjects in a structured group activity. An illumination recipe that compensates for the deficiency of lighting or of participant sleep or behavior patterns, or age- or disease-related changes, to evoke, shift, or align circadian response and improve behaviors such as classroom alertness, relaxation, excitability, attention, or focus. Systems may receive sensed light values and automatically apply high- and/or low-CER illumination to effect the intended circadian phase. 1. A system for tuning , control or remediation of a biological light-responsive state , the system comprising a light controller to control an illumination source and a sensing feedback system connected to or communicating with the controller and comprising a physiological sensor worn by or attached to a subject , the controller being operative to set at least one of: spectral distribution , light intensity , light directionality , light periodicity , and a bioactive spectral band , during a programmed or specified time , providing a lighting prescription to supplement ambient or other illumination experienced by the subject in a manner effective to shift or to entrain a circadian response of the subject and thereby improve the subject's performance under changing , disrupted , unnatural extended , geographically discontinuous or spectrally deficient or inappropriate lighting , applying an illumination ...

Optical Guide For Diffusing Light Radiation, Module And Device For Transcutaneous Irradiation, In Particular Transcranial Irradiation

The invention relates mainly to an optical guide for diffusing a light radiation through a surface, which is essentially characterized in that it includes a base ( 3,31 ) comprising or able to hold at least one diffusion rod ( 2, 2 a; 35 a, 35 b, 35 c ) whose lower diffusion end ( 7, 7 a; 38 a, 38 b, 38 c ) protrudes from said base ( 3 ) and is intended to be applied on or near said surface, and whose upper collecting end ( 6,6 a; 37 a, 37 b, 37 c ) is intended to be located near and opposite a power supplied light source ( 36 a, 36 b, 36 c ), and in that the diffusion rod ( 2, 2 a; 35 a, 35 b, 35 c ) comprises a material able to transmit light from its collecting end ( 6,6 a; 37 a, 37 b, 37 c ) up to its diffusion end ( 7, 7 a; 38 a, 38 b, 38 c ). The invention also relates to an irradiation module and to an irradiation device adapted to the transcranial and/or transcutaneous irradiation by light radiation.

User-wearable devices that monitor exposure to blue light and recommend adjustments thereto

Described herein are user-wearable devices that include an optical sensor, and methods for use therewith. In certain embodiments, an optical sensor of a user-wearable device (e.g., a wrist-worn device) is used to detect blue light that is incident on the optical sensor and to produce a blue light detection signal indicative thereof, and thus, indicative of the response of the user's intrinsically photosensitive Retinal Ganglion Cells (ipRGCs). In dependence on the blue light detection signal, there is a determination of a metric indicative of an amount of blue light detected by the optical sensor. The metric is compared to a corresponding threshold, and a user notification is triggered in dependence on results of the comparing, wherein the user notification informs a person wearing the user-wearable device to adjust their exposure to light.

ILLUMINATED EYEWEAR DEVICE

An illuminated eyewear device is described. The illuminated eyewear device comprises a transparent substrate and one or more light sources mounted around the perimeter of the transparent substrate. The output of the one or more light sources is arranged to be coupled into, and propagates within, the transparent substrate. Applied to an inner surface of the transparent substrate are a plurality of refractive light scattering means designed to break the condition for total internal reflection of the light generated by the one or more light sources. As well as being mobile, compact and easy to integrate into everyday life, the above described illuminated eyewear device address the known problem of glare experienced by users of those devices known in the art since the light sources are not directly imaged into the user eye. 1. An illuminated eyewear device comprising a transparent substrate having a first outer surface and a second inner surface and one or more light sources mounted around the perimeter of the transparent substrate , the output of the one or more light sources is coupled into , and propagates within , the transparent substrate ,wherein the transparent substrate further comprises a plurality of refractive light scattering elements located within the transparent substrate or upon the second inner surface that provide a means to redirect the light out of, and away from, the transparent substrate via the second inner surface.2. An illuminated eyewear device as claimed in wherein the one or more light sources emit a single wavelength of visible light.3. An illuminated eyewear device as claimed in wherein the one or more light sources emit different visible wavelengths of light.4. An illuminated eyewear device as claimed in wherein the transparent substrate comprises a glass or a transparent polymer.5. An illuminated eyewear device as claimed in wherein the plurality of refractive light scattering elements comprise a transparent or translucent material having ...

DEVICE AND METHOD FOR TREATMENT OF TINNITUS

A device for the therapeutic treatment of tinnitus is disclosed, wherein a device for treatment of tinnitus comprising a topographic geometrical matrix and a support, wherein each topographic geometrical matrix is applied to the support and comprising 130-. (canceled)31. A passive fractal-based device applicable by a patient comprising at least one topographic geometrical matrix attached to a support , wherein each topographic geometrical matrix comprises:an outer circle that completely encompasses at least one inner circle, wherein the outer circle and the at least one inner circle do not share a tangential arc point,wherein the diameter of the outermost circle is at most 130 mm, and the diameter of the innermost circle is at most 3 mm, and wherein the ratio between the diameter of the outermost circle and the diameter of the next circle is at least 1.3;wherein the ratio between the diameter of the outer circle and the diameter of the at least one inner circle is the ratio between any number being at least 2 in Fibonacci's sequence of numbers and any number lower than that being at least 1 in said Fibonacci's sequence of numbers, including ±10% for each ratio.32. The device according to claim 31 , wherein the relationship between the outermost circle and the innermost circle of the matrix is 13±10%.33. The device according to claim 31 , wherein the topographic geometrical matrix has a diameter of the outermost circle ranging from 2 mm to 130 mm claim 31 , and a diameter of the innermost circle ranging from 0.5 mm to 3 mm.34. The device according to claim 31 , wherein the matrix comprises several concentric circles and one or more rings formed between the circles are closed.35. The device according to claim 31 , wherein the line width of the circles of the topographic geometrical matrix ranges from 0.05 mm to 2.0 mm.36. The device according to claim 31 , wherein the topographic geometrical matrix is fully or partially colored with one or more metallic colors.37. The ...

Light therapy system and method

A light therapy system ( 12 ) for administering a controllable melanopic luminous exposure includes a controllable lighting assembly ( 16 ) for use in delivering the desired luminous exposure. The system further includes a visual display means ( 18 ) for presenting at the same time a visual output such as a video to the patient. A target melanopic luminous exposure for administration to the patient is received by a controller 24 . This target is then adjusted to compensate for an additional melanopic luminous exposure which the visual display means generates in displaying the visual output. A control schedule is then generated for controlling an illuminance of the lighting assembly to deliver over a defined treatment period the adjusted target melanopic luminous exposure. The lighting assembly is then controlled according to the control schedule. In this way both the visual output of the visual display means and the light output of the lighting assembly can be administered, while ensuring that the original target melanopic luminous exposure is delivered and not exceeded.

Light exposure apparatus

A light exposure apparatus emits light which activates the body of the user. The light exposure apparatus includes a blue light source which emits blue light and a red light source which emits red light. The light includes blue light and red light. Blue light has a peak wavelength in a range from 445 nm to 500 nm. Red light has a peak wavelength in a range from 600 nm to 680 nm. The intensity of the peak wavelength of blue light is the strongest in the spectrum of the light, and the intensity of the peak wavelength of red light is the second strongest in the spectrum of the light. The relative intensity of the peak wavelength of the red light with respect to the peak wavelength of the blue light is in a range from 0.1 to 0.5 inclusive.

PHOTOTHERAPEUTIC SYSTEMS INCLUDING SPREADING AND COLLIMATING FEATURES AND RELATED TECHNOLOGY

A phototherapeutic system in accordance with an embodiment of the present technology includes a housing at least partially defining an irradiation zone configured to accommodate at least a portion of a human subject. The system further comprises an ultraviolet (UV) radiation source configured to direct UV radiation along a radiation path extending from the radiation source to the irradiation zone. The radiation source includes a concentrated source at which UV radiation is generated, and a collimating reflector (or lens) configured to reflect (or refract) the UV radiation and thereby increase collimation of the UV radiation. The system still further comprises a filter, a spreader, and a collimator disposed successively farther downstream from the radiation source along the radiation path. The spreader and the collimator respectively decrease and increase collimation of the UV radiation before the UV radiation reaches the subject. 1. A phototherapeutic system , comprising:a housing at least partially defining an irradiation zone, wherein the irradiation zone is configured to accommodate at least a portion of a human subject;an ultraviolet (UV) radiation source configured to direct UV radiation along a radiation path extending from the radiation source to the irradiation zone;a filter disposed along the radiation path downstream from the radiation source;a spreader disposed along the radiation path downstream from the filter; anda collimator disposed along the radiation path downstream from the spreader.2. The phototherapeutic system of example 1 wherein:the radiation source is configured to direct at least partially collimated UV radiation along the radiation path;the spreader decreases collimation of UV radiation from the radiation source; andthe collimator increases collimation of UV radiation from the radiation source.3. The phototherapeutic system of example 1 wherein the radiation path includes a fold downstream from the spreader and upstream from the collimator ...

APPARATUS FOR IMPROVING MENTAL WELL BEING, AND A METHOD THEREOF

An earpiece and a method of for improving mental well-being in a person, using flashing light suppled into the ear or ears of a person. The earpiece can be worn on one ear instead of two for inducing a binaural beats effect. 1. An apparatus for improving mental well-being comprising:at least one earpiece;the at least one earpiece having at least one light source arranged to emit flashing light into the canal of an ear wearing the earpiece.2. An apparatus for improving mental well-being as claimed in claim 1 , whereinthe light source emits light in a periodic flashing frequency.3. An apparatus for improving mental well-being as claimed in claim 2 , whereinthe flashing frequency is 6 Hz.4. An apparatus for improving mental well-being as claimed in claim 2 , whereinthe apparatus is capable of adjusting the flashing frequency in response to physiological feedback.5. An apparatus for improving mental well-being as claimed in claim 4 , whereinthe apparatus comprises a heartbeat monitor for obtaining physiological feedback from heartbeat.6. An apparatus for improving mental well-being as claimed in claim 5 , whereinthe heartbeat monitor is an electrocardiogram sensor.7. An apparatus for improving mental well-being as claimed in claim 5 , whereinthe heartbeat monitor is a photoplethysmography sensor.8. An apparatus for improving mental well-being as claimed in claim 1 , whereinthe at least one earpiece has a further light source arranged to emit light into the same ear canal; andthe one light source and the further light source are each capable of emitting light in different electromagnetic frequencies; andthe one light source and the further light source are capable of emitting light alternatively.9. An apparatus for improving mental well-being as claimed in claim 1 , further comprisinganother earpiece having a light source arranged to emit light into the canal of the other ear;the light sources of the two earpieces capable of emitting in the same flashing frequency.10. An ...

Nanocrystals on fibers

The present invention relates inter alia to light- and/or irradiation-emitting fibers comprising nanocrystals, in particular quantum dots and nanorods, their preparation and use. The fiber may have a fiber core 10 , an outer first electrode 20 , a light emitting layer 30 , a radiation transmissive second electrode 40 positioned over the organic light emitting layer 30 . Eventually the fiber may also comprise an optional radiation transmissive moisture and/or air barrier layer 50 and/or an optional radiation transmissive encapsulating material 60.

OPTOGENETIC CONTROL OF BEHAVIORAL STATE

The present disclosure provides methods of modulating a feature of a behavioral state. The methods involve inhibiting or activating the activity of a bed nucleus of stria terminalis (BNST) neuron, a BNST subnucleus, or a neuronal output to or from a BNST neuron. Animals encounter environmental conditions that require rapid switching among different behavioral states to increase the likelihood of survival and reproduction. 1. A method of modulating a feature of a behavioral disorder , the method comprising inhibiting or activating the activity of a bed nucleus of stria terminalis (BNST) neuron , a BNST subnucleus , or a neuronal output to or from a BNST neuron , wherein the feature is a behavioral feature or a physiological feature.2. The method of claim 1 , wherein the behavioral state is anxiety.3. The method of claim 1 , wherein the feature is respiratory rate claim 1 , risk avoidance claim 1 , or aversion.4. The method of claim 1 , wherein said modulating comprises inhibiting a BNST neuron claim 1 , wherein said inhibiting is anxiolytic.5. The method of claim 1 , wherein said modulating comprises inhibiting the oval nucleus of a BNST claim 1 , wherein said inhibiting is anxiolytic and reduces respiratory rate.6. The method of claim 1 , wherein said modulating comprises activating a basolateral amygdala (BLA) input to a BNST neuron by activating a BLA pyramidal neuron claim 1 , wherein said activating reduces risk avoidance and reduces respiratory rate.7. The method of claim 1 , wherein said modulating comprises stimulating an anterodorsal BNST neuron projection to the lateral hypothalamus claim 1 , wherein said stimulating reduces risk avoidance claim 1 , and has substantially no effect on respiratory rate.8. The method of claim 1 , wherein said modulating comprises activating an anterodorsal BNST neuron projection to the parabrachial nucleus claim 1 , wherein said activating reduces respiratory rate claim 1 , and has substantially no effect on risk avoidance ...

Therapeutic devices and methods to improve body functions

Methods and therapeutic devices with noninvasive means for improving brain function, improving eye health, improving digestive system health and improving immune functions are described. The non-invasive means is selected from electrical stimulation, heat stimulation, IR (infrared) radiation, mechanical stimulation or their combinations. In some embodiments, the method and device utilize stimulation to selected skin area on human body to achieve desired therapeutical effects. 1. A device for improving brain function in a subject in need , said device comprising:one or more infra-red light emitting units facing the skin of the head; andone or more electrode assembly that can be attached to the skin of the head; andat least one speaker unit.2. The device of claim 5 , wherein the electrode can generate electric pulse at about 35 Hz to about 45 Hz or about 0.1 Hz to about 4 Hz.3. The device of claim 5 , wherein the speaker can generate sound pulse at about 35 Hz to about 45 Hz or about 0.1 Hz to about 4 Hz.4. A device having a shape of eye mask for improving eye health claim 5 , said device comprising:one or more infra-red LED facing the eye; andone or more heating element.5. The device of claim 4 , wherein the heating element can maintain the temperature at about 40 to 55 degree at the skin contact surface.6. A method for improving brain function in a subject in need thereof claim 4 , the method comprising administering a non-invasive electrical stimulus having a frequency of about 35 Hz to about 45 Hz to the subject's skin surface when a subject is awake and a non-invasive electrical stimulus having a frequency of about 0.1 Hz to about 4 Hz to the subject's skin when a subject is in sleep.7. The method of claim 6 , wherein additional heat stimulation is applied to the head.8. The method of claim 6 , wherein additional infra-red light stimulation is applied to the head.9. The method of claim 6 , wherein additional mechanical stimulation having a frequency of about 35 ...

LUMINAIRE FOR ENHANCED COLOR RENDITION AND WELLNESS

In one aspect, a luminaire is provided for illumination, in which the luminaire has a normalized spectral power distribution (SPD) curve for promoting human wellness, the normalized SPD curve having the following percentage areas for the following wavelength domains, the normalized SPD curve including spectral energy in a 620 nm to 640 nm region of the SPD curve ranging from 9.5% to 10.5% of a total of an area for a normalized SPD curve; spectral energy in a 640 nm to 660 nm region of the SPD curve ranging from 7.25% to 9.8% of the total of the area of the normalized SPD curve; spectral energy in a 660 nm to 680 nm region of the SPD curve ranging from 4.8% to 7.8% of the total of the area for the normalized SPD curve; spectral energy in a 680 nm to 700 nm region of the SPD curve ranging from 2.75% to 5.5% of the total of the area for the normalized SPD curve; and a remainder of spectral energy of the total normalized SPD curve is in a 400 nm to 620 nm region area of the SPD curve. 120-. (canceled)21. A luminaire having a normalized spectral power distribution (SPD) curve for promoting human wellness , the normalized SPD curve having the following percentage areas for the following light wavelength domains , the normalized SPD curve comprising:spectral energy in a 620 nm to 640 nm region of the SPD curve ranging from 9.5% to 10.5% of a total of an area for a normalized SPD curve; spectral energy in a 660 nm to 680 nm region of the SPD curve ranging from 4.8% to 7.8% of the total of the area for the normalized SPD curve; and', 'spectral energy in a 680 nm to 700 nm region of the SPD curve ranging from 2.75% to 5.5% of the total of the area for the normalized SPD curve, wherein light emitted from the luminaire have skin tone indices selected from the group consisting of R13 being equal to 95 or greater, R15 being equal to 92 or greater, and combinations thereof., 'spectral energy in a 640 nm to 660 nm region of the SPD curve ranging from 7.25% to 9.8% of the total of ...

NON-INVASIVE ENERGY UPCONVERSION METHODS AND SYSTEMS

Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by placing a nanoparticle having a metallic shell on at least a fraction of a surface in a vicinity of a target structure in a subject and applying an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The nanoparticle is configured, upon exposure to a first wavelength λ, to generate a second wavelength λof radiation having a higher energy than the first wavelength λ. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods. 1. A system for production of emitted light inside a medium to be treated for a disease or disorder , comprising:a pharmaceutical carrier;a phosphorescent or luminescent material which, upon activation by an activation energy which penetrates said medium to be treated, produces said emitted light from inside of said medium to be treated to treat the disease in situ.2. The system of claim 1 , further comprising:a metallic structure attached to the phosphorescent or luminescent material.3. The system of claim 1 , wherein said metallic structure comprises at least one of Au claim 1 , Ag claim 1 , Cu claim 1 , Pt claim 1 , Pd claim 1 , Co claim 1 , Ru claim 1 , Rh claim 1 , Al claim 1 , Ga claim 1 , or a combination or alloys or layers ...

CAPSULE WITH WHOLE BODY LED PHOTO-THERAPY

A personal therapy compartment includes a base of size to receive a human patient. The compartment includes a bed in the base said bed being made of a light transmissive material. An array of lights mounted is below the bed to transmit light onto a body supported on the bed. A control panel controls at least the wavelength, intensity and pulsation of the light. 120-. (canceled)21. A personal therapy compartment comprising:a base extending from a first end to a second end, wherein the base is of size to receive a human being wherein the base includes a base surface,a bed supported by and separated from the base surface of the base, said bed having an upper surface and a lower surface and being made of a light transmissive material and wherein the lower surface of the bed and the base surface are spaced apart from each other,at least two spaced apart bed arrays of light emitting diodes located between the lower surface of the bed and the base surface of the base wherein each bed array of light emitting diodes is adapted to transmit visible light through the bed and onto a body of the human being supported on the bed,a cover pivotally attached to the base proximate the first end and wherein the cover comprises:a divider panel positioned proximate the second end of the cover, wherein the divider panel is configured to be positioned about a neck of the human to provide different environments for the human's body and the human's head; anda control panel configured to control one or more selected array of light emitting diodes of the at least two spaced apart bed arrays and the facial array, wherein the control panel is configured to control at least intensity and duration of beams of light emitted from the selected array of light emitting diodes such that the beams of light are transmitted onto a person laying on the upper surface of the bed.22. The compartment of and further comprising:a facial array support by the divider panel, wherein the facial array comprises one or ...

TEXTILE COVERED WITH AN ACTIVE OUTSIDE SURFACE AND AN ACTIVE INSIDE SURFACE COMPRISING OPTICAL FIBERS

A textile has an active outside surface and an active inside surface including optical fibers covering at least partially the active outside surface, wherein the active outside surface captures light, which is transmitted by the optical fibers to the active inside surface. 115-. (canceled)16. A textile having an active outside surface and an active inside surface comprising optical fibers covering at least partially the active outside surface , wherein the active outside surface captures light , which is transmitted by the optical fibers to the active inside surface.17. The textile as claimed in claim 16 , wherein at least the entire active outside or the entire active inside surface is covered with the optical fibers claim 16 , said active outside surface and the active inside surface are connected by the optical fibers claim 16 , and said active inside surface dissipates the light captured by the active outside surface.18. The textile as claimed in claim 16 , wherein the optical fibers are textile-processable fibers.19. The textile as claimed in claim 16 , wherein the optical fibers are made of Polymethylmethacrylate (PMMA) claim 16 , Polycarbonate (PC) claim 16 , or Polymethylmethacrylate (PMMA) claim 16 , Polycarbonate (PC) modified formulations with varying amounts of other comonomers claim 16 , additives claim 16 , and fillers or are made of extruded glass (silicia).20. The textile as claimed in claim 16 , wherein optical fibers are treated superficially such that the textile-processable fibers are damaged in a defined manner so that light is captured at an end or a lateral surface of the optical fibers and the light is dissipated over the lateral surface or over the opposite end of the optical fibers.21. The textile as claimed in claim 16 , wherein the optical fibers are knitted claim 16 , woven claim 16 , tufted or sewn in the active outer surface or in the active inner surface.22. A garment for a human comprising at least the textile as claimed in .23. The ...

CIRCADIAN SENSOR SYSTEM

A circadian health system (CHS) provides for improving the health of Alzheimer's patients and other persons by controlling their exposure to circadian lighting. Circadian sensor devices (CSDs) are distributed in a living space, e.g., at about eye-level positions on respective walls of room. Each CSD includes a spectral sensor for measuring the intensity of light at various wavelength bands. Captured spectra can be compared to circadian light signatures so that the sources of circadian light can be identified. The identifications then allow predetermined high-resolution, e.g., 5 nm, spectra in the circadian wavelengths of 450-500 nm to be determined. The spectra can then be used to control circadian lighting to provide prescribed doses of circadian stimulus.

Noninvasive, regional brain thermal stimulation for inducing relaxation

Methods, systems and devices for reducing anxiety, including increasing relaxation and/or calm. In some variations these methods may include reducing anxiety, increase relaxation and/or calm by non-invasive temperature regulation of the frontal cortex prior to and/or during sleep. The subject may have an anxiety disorder, or may not have a diagnosed anxiety disorder.

Three-channel tuned led lamp for producing biologically-adjusted light

An LED lamp comprising a housing, a drive circuit, and a plurality of LED dies driven by the drive circuit, The plurality of LED dies may be in a ratio of at least one of 15 mint LED dies to 5 hyper red LED dies to 4 blue LED dies and 1 mint LED die to 1 hyper red LED die to 1 blue LED die. The drive circuit may operate the LED dies such that a relative peak intensity of the blue LED dies is within the range from 80%-90% or 90%-100% of a peak intensity of the hyper red LED dies, and a relative peak intensity of the mint LED dies is within the range of 50%-60% or 30%-40% of the peak intensity of the hyper red LED dies.

Lighting control system, lighting system, and lighting control method

A lighting control system controls a light source that emits light to a space in which subjects stay. The lighting control system includes: an communication interface that obtains stay schedule information indicating scheduled periods in an operation period after a first time and before a second time later than the first time, the scheduled periods being periods during each of which a corresponding one of the subjects is to stay in the space; and a processor that creates an illumination schedule for causing the light source to emit the light, based on the stay schedule information, and causes the light source to emit the light according to the illumination schedule created. The processor creates, based on the stay schedule information, the illumination schedule for causing the light source to emit the light during a period including a scheduled period common to at least two of the subjects.

Control and Characterization of Psychotic States

Provided herein are methods of inducing psychosis in animals using light-responsive opsins and methods of identifying or screening compounds that may be useful in treating psychosis. 112-. (canceled)13. A method of identifying a candidate compound for treating psychosis , the method comprising:a) exposing layer V pyramidal neurons in the prefrontal cortex of a transgenic rat or mouse to light, wherein the genome of the transgenic rat or mouse comprises a nucleic acid sequence encoding a light-responsive depolarizing opsin operably linked to a thymus cell antigen 1 (Thy1) promoter, wherein a subset of layer V pyramidal neurons express on their cell membrane the light-responsive depolarizing opsin, wherein the light-responsive depolarizing opsin comprises an amino acid sequence having at least 90% amino acid sequence identity with the amino acid sequence set forth in one of SEQ ID NOs:1-7, and wherein exposure of the subset of layer V pyramidal neurons to light induces depolarization of the membrane and induces a psychotic state in the transgenic rat or mouse;b) administering the compound to the transgenic rat or mouse having the induced psychotic state; andc) measuring a psychotic state of the transgenic rat or mouse before and after administering the compound, wherein a decrease in the psychotic state indicates that the compound is a candidate for treating psychosis.14. The method of claim 13 , wherein the psychotic state measurement is a behavioral measurement.15. The method of claim 13 , wherein the psychotic state measurement is a cellular measurement.16. The method of claim 13 , further comprising a step of administering a D2 agonist to the animal before administration of the compound.1749-. (canceled)50. The method of claim 14 , wherein the behavioral measurement is social exploration.51. The method of claim 13 , wherein the light-responsive opsin comprises an amino acid sequence having at least 90% identity to the amino acid sequence set forth in SEQ ID NO:1. ...

PANEL SYSTEMS WITH CIRCADIAN LIGHTING

Panel systems for displaying digital content. The panel systems have one or more LED-based lighting channels adapted to generate a circadian-inducing blue light output in first operational mode and a less-circadian-inducing blue light output in a second operational mode. The circadian-inducing blue light can have a first circadian-stimulating energy characteristic related to the associated first spectral power distributions of light generated in the first operational mode, and the non-circadian-inducing blue light can have a second circadian-stimulating energy characteristic related to the associated second spectral power distribution of light generated in the second operational mode. Disclosure methods of generating digital display content with the panel systems described herein. The methods can generate a circadian-inducing blue light output in first operational mode and a less-circadian-inducing blue light output in a second operational mode. 1. A panel system for displaying digital content , wherein the panel system comprises:one or more LED-based lighting channels adapted to generate a circadian-inducing blue light output in a first operational mode and a less-circadian-inducing blue light output in a second operational mode.238-. (canceled) This application claims benefit of U.S. Provisional Application No. 62/616,401 filed Jan. 11, 2018. U.S. Provisional Application No. 62/616,404 filed Jan. 11, 2018; U.S. Provisional Application No. 62/616,414 filed Jan. 11, 2018; U.S. Provisional Application No. 62/616,423 filed Jan. 11, 2018; U.S. Provisional Application No. 62/634,798 filed Feb. 23, 2018; U.S. Provisional Application No. 62/712,182 filed Jul. 30, 2018; U.S. Provisional Application No. 62/712,191 filed Jul. 30, 2018; U.S. Provisional Patent Application No. 62/757,672 filed Nov. 8, 2018; U.S. Provisional Patent Application No. 62/757,664 filed Nov. 8, 2018; U.S. Provisional Patent Application No. 62/758,447 filed Nov. 9, 2018; and International Patent ...

METHODS, SYSTEMS, AND APPARATUS FOR REDUCING THE FREQUENCY AND/OR SEVERITY OF PHOTOPHOBIC RESPONSES OR FOR MODULATING CIRCADIAN CYCLES

The present disclosure describes systems, methods, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles by controlling light exposure to cells in the human eye in certain wavelengths, such as 480 nm and 620 nm, and a visual spectral response of the human eye. Embodiments of an optical filter are described. In one embodiment an optical filter may be configured to transmit less than a first amount of light in certain wavelengths, and to transmit more than a second amount of light weighted across the visual spectral response. Methods of use and methods of manufacturing optical filters are also described. 1. An apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles by controlling exposure of cells in a human eye to light having about a 620 nm wavelength , the apparatus comprising:an optical filter configured to transmit less than a first amount of light at about a 620 nm wavelength and to transmit more than a second amount of light weighted across a visual spectral response.2. The apparatus of claim 1 , wherein said first amount of light is approximately all of the light at about the 620 nm wavelength and wherein said second amount of light is approximately all of the light outside of about the 620 nm wavelength claim 1 , weighted across the visual response spectrum.3. The apparatus of claim 1 , wherein said first amount of light is substantially all light above a short-pass filter wavelength between about 580 nm and 650 nm and said second amount of light is all light across the visual spectral response with a wavelength below said short-pass filter wavelength.4. The apparatus of claim 1 , wherein said second amount of light includes a third amount of light having a wavelength that is lower or greater than about the 620 nm wavelength.5. The apparatus of claim 1 , wherein said second amount of light includes a third amount of light having a wavelength ...

Circadian friendly led light source

Methods and apparatus for providing circadian-friendly LED light sources are disclosed. A light source is formed to include a first LED emission (e.g., one or more LEDs emitting a first spectrum) and a second LED emission (e.g., one or more LEDs emitting a second spectrum) wherein the first and second LED emissions are combined in a first ratio and in a second ratio such that while changing from the first ratio to the second ratio the relative circadian stimulation is varied while maintaining a color rendering index above 80.

APPARATUS AND METHOD FOR INHIBITING MELATONIN SYNTHESIS IN A HORSE

An apparatus for inhibiting melatonin synthesis in a horse comprises a blinker having an internal surface of which at least a part is diffusing. A source of light is positioned for direction into the horse's eye by the diffusing-surface. The light source and diffusing surface are configured such that the light directed into the horse's eye is blue. 1. A light-based method of inducing physiological change , the method comprising the step of shining light from an artificial blue light source into just one eye of a female horse or other animal , each day for at least 6 weeks , causing a substantial suppression of melatonin production sufficient to induce physiological change , the physiological change being advancing a breeding season of the horse or other animal , wherein the treatment regime is at least as effective as maintaining the horse or other animal indoors under barn lighting to advance the breeding season of the horse or other animal.2. The method of claim 1 , in which the light source provides only blue light with a peak wavelength in the range 440 nm-490 nm.3. The method of claim 1 , in which the light source provides only blue light with a peak wavelength in the range 459 nm-484 nm.4. The method of claim 1 , in which the light source provides blue light with an intensity of under 100 lux at the just one eye of the female horse or other animal.5. The method of preceding claim 4 , in which the light source provides blue light with an intensity of between 10-50 lux at the just one eye of the female horse or other animal.6. The method of claim 1 , in which the light source is turned on before dusk.7. The method of claim 1 , including the step of providing to the horse or other animal a combined total of natural and artificial light for at least approximately 16 hours during each 24 hour period.8. The method of claim 1 , comprising the step of keeping the horse or other animal outdoors whilst the low intensity light is shone in just one eye of the horse or ...

Multi-channel systems for providing tunable light with high color rendering and biological effects

The present disclosure provides systems for generating tunable white light. The systems include a plurality of LED strings that generate light with color points that fall within red, blue, and cyan color ranges, with each LED string being driven with a separately controllable drive current in order to tune the generated light output.

LIGHTING CONTROL SYSTEM

A lighting control system includes: a biological information obtainer which obtains biological information related to a biological body of a user; an environmental information obtainer which obtains environmental information related to a surrounding environment of the user; a severity determiner which determines a severity of premenstrual syndrome (PMS) based on the biological information obtained by the biological information obtainer and the environmental information obtained by the environmental information obtainer; and a lighting controller which controls a lighting device based on the severity determined by the severity determiner. 1. A lighting control system , comprising:a biological information obtainer which obtains biological information related to a biological body of a user;an environmental information obtainer which obtains environmental information related to a surrounding environment of the user;a severity determiner which determines a severity of premenstrual syndrome (PMS) based on the biological information obtained by the biological information obtainer and the environmental information obtained by the environmental information obtainer; anda lighting controller which controls a lighting device based on the severity determined by the severity determiner.2. The lighting control system according to claim 1 , further comprisinga biological period determiner which determines whether or not the user is in a period of developing PMS, based on the biological information obtained by the biological information obtainer, whereinthe severity determiner determines the severity when the biological period determiner determines that the user is in the period of developing PMS.3. The lighting control system according to claim 1 , whereinthe lighting controller controls luminance, a color temperature, and a light emission duration of the lighting device, based on the severity.4. The lighting control system according to claim 3 , whereinthe lighting controller ...

METHODS FOR PREVENTING AND TREATING MOTOR-RELATED NEUROLOGICAL CONDITIONS

Methods for preventing or treating motor-related neurological conditions include using ocular light therapy in connection with a conventional therapy for a motor-related neurological condition, such as a drug regimen, to adjust levels of melatonin and/or dopamine in the body of a subject. The ocular light therapy may include elevated levels of blue-green light or green light (e.g., light within a wavelength range of 460 nm to 570 nm, 490 nm to 570 nm, about 520 nm to 570 nm, etc.). The ocular light therapy may also include reduced levels of amber, orange and/or red light. Methods for diagnosing motor-related neurological conditions include use of ocular light therapy to cause a subject to temporarily exhibit one or more symptoms of any motor-related neurological condition to which the subject is predisposed, or which the subject may already be experiencing. A temporary increase in such symptoms may be effected by ocular administration of light including increased amounts of amber, orange and/or red light. 1. An ocular light therapy method , comprising:simultaneously administering above-ambient peaks of light to a subject, the above-ambient peaks of light having intensities that exceed intensities of corresponding peaks of ambient light in the following ranges:a first above ambient peak of light in a blue-to-blue-green range of wavelengths of about 460 nm to about 520 nm; anda second above ambient peak of light in a green range of wavelengths of above 520 nm to less than 540 nm2. The method of claim 1 , wherein administering occurs for about one hour.3. The method of claim 1 , wherein administering occurs for about thirty minutes.4. The ocular light therapy method of claim 1 , further comprising:administering below-ambient light or no light in a range of wavelengths of more than 570 nm to 750 nm to the subject while simultaneously administering the above-ambient peaks of light to the subject.5. The method of claim 1 , wherein simultaneously administering the above- ...

Methods For Generating Melatonin-Response-Tuned White Light With High Color Rendering

The present disclosure provides methods for generating tunable white light with controllable circadian energy performance. The methods use a plurality of LED strings to generate light with color points that fall within blue, yellow/green, red, and cyan color ranges, with each LED string being driven with a separately controllable drive current in order to tune the generated light output. Different light emitting modes can be selected that utilize different combinations of the plurality of LED strings in order to tune the generated white light. 1. A method of generating white light , the method comprising:producing light from a first light emitting diode (“LED”) string that comprises a blue LED with peak wavelength of between about 405 nm and about 470 nm;producing light from a second LED string that comprises a blue LED with peak wavelength of between about 405 nm and about 470 nm;producing light from a third LED string that comprises a blue LED with peak wavelength of between about 405 nm and about 470 nm, a fourth LED string that comprises a cyan LED with peak wavelength of between about 485 nm and about 520 nm, or both the third LED string and the fourth LED string; andpassing the light produced by each of the first, second, third, and fourth LED strings through one of a plurality of respective luminophoric mediums;combining the light exiting the plurality of respective luminophoric mediums together into white light;wherein the combined white light corresponds to at least one of a plurality of points along a predefined path near the black body locus in the 1931 CIE Chromaticity Diagram.2. The method of claim 1 , wherein:the light produced from the first LED string is passed through a first recipient luminophoric medium that comprises a first luminescent material, wherein light exiting the first luminophoric medium comprises unsaturated light having a first color point within a blue color range;the light produced from the second LED string is passed through a ...

LIGHT THERAPY AS AN ADJUVANT TO CAROTID ENDARTERECTOMY

A method for treating a subject is provided. The method includes performing surgery on the subject such as, for example, a carotid endarterectomy. Light therapy is administered to the subject as an adjuvant to the surgery. 1. A method for treating a subject , comprising:performing surgery on the subject; andperforming light therapy on the subject as an adjuvant to the surgery.2. The method of claim 1 , wherein the surgery is selected from the group consisting of open heart surgery claim 1 , heart valve replacement surgery and carotid endarterectomy.34-. (canceled)5. The method of claim 1 , wherein the light therapy is performed within 8 hours of the surgery.6. (canceled)7. The method of claim 1 , wherein the light therapy is performed within 4 hours of the surgery.8. The method of claim 1 , wherein the light therapy is performed within 2 hours of the surgery.9. (canceled)10. The method of claim 1 , wherein the light therapy is performed prior to the surgery.11. The method of claim 1 , wherein the light therapy is performed after the surgery.12. The method of claim 1 , further comprising:determining the level of at least one biomarker selected from the group consisting of cytokines and chemokines; andrepeating the step of performing the light therapy if the at least one biomarker is outside of a predetermined range.13. The method of claim 12 , further comprising repeating the step of performing the light therapy if the at least one biomarker is above a predetermined threshold value.14. The method of claim 1 , further comprising:{'sub': ['i1', 'i2', 'i1', 'i2', 'i'], '#text': 'determining the levels Land Lat corresponding times tand tof at least one biomarker B; and'}{'sub': ['i', 'i', 'i', 'i2', 'i1'], '#text': 'repeating the step of performing the light therapy if Δ≥k, wherein Δ=|L−L|.'}15. The method of claim 1 , further comprising:{'sub': ['i', '1', 'n'], '#text': 'determining the levels in the subject of a plurality of biomarkers Bϵ[B, . . . , B], wherein n≥2; ...

Wireless optogenetic device and associated radiation system

A wireless optogenetic device in proximity to a neural cell of a subject includes a body configured to hold light transducing materials arranged to up-convert electromagnetic radiation in infrared or near-infrared spectrum into light in the visible spectrum to affect activity of the neural cell. The body allows electromagnetic radiation in infrared or near-infrared to reach the light transducing materials. A radiation system includes a radiation probe for irradiating a wireless optogenetic device with electromagnetic radiation in infrared or near-infrared spectrum from a radiation source. The system further includes a movement mechanism for moving the radiation probe, a detector for detecting a location of the wireless optogenetic device, and a controller for controlling the movement mechanism based on the detected location of the wireless optogenetic device such that the radiation probe is arranged to irradiate the wireless optogenetic device at the detected location with the electromagnetic radiation.

Method and Apparatus for Reducing or Preventing Myopia

A method and apparatus for reducing or preventing myopia is presented. In one mode, a display includes a front surface and a region is provided along at least one area of the front surface. The region provides temporal stimulation to a user viewing the display, which results in the prevention or reduction of myopia in a person viewing the display without the need for accurate accommodation or binocular fixation. In a second mode, a stand-alone device provides temporal stimulation to a user viewing the display, which results in the prevention or reduction of myopia in a person viewing the display. In a third mode, the temporal stimulation is projected into the viewer's field of view, which results in the prevention or reduction of myopia in a person viewing the projection.

RESTRUCTURING NEURAL PATHWAYS IN THE BRAIN WITH A COMBINATION OF TRANSCRANIAL THERAPIES

Brain dysfunction can be treated by restructuring neural pathways in the brain. A desired area in the brain to form a new neural pathway is selected. The area receives a sequential combination of (1) transcranial photobiomodulation therapy (PBMT) including a series of pulses having a frequency matched to a target brain wave and (2) another transcranial stimulation (e.g., transcranial direct current electrical stimulation and/or transcranial magnetic stimulation). The different stimulation mechanisms ensure that neuroplasticity occurs to restructure a neural pathway that is dysfunctional in nature to a new neural pathway that conducts normally. 1. A method comprising:delivering a transcranial stimulation at an intensity and for a time to an area of a brain of a patient requiring stimulation, wherein the area of the brain corresponds to a desired neural pathway; anddelivering a light signal in a transcranial manner to the area of the brain for a second time, wherein the light signal comprises a series of pulses having a frequency matched to a target brain wave;wherein the brain undergoes neuroplasticity to form the desired neural pathway in response to the transcranial stimulation and the light signal,wherein the transcranial stimulation and the light signal are delivered sequentially,wherein the transcranial stimulation and the light signal are delivered by a same device, wherein the same device comprises a magnetic source or an electrical source to provide the transcranial stimulation and a light source to provide the light signal, andwherein the light source comprises a cluster of light delivery sources, the cluster of light delivery sources comprises:a first light delivery source configured to generate a first portion of the light signal in a super-pulsed operating mode;a second light delivery source configured to generate a second portion of the light signal in a pulsed operating mode or a continuous operating mode; anda third delivery light source configured to ...

SYSTEMS AND METHODS FOR CONTROLLING THE SPECTRAL CONTENT OF LED LIGHTING DEVICES

Luminaries, fixtures, systems and methods of providing both spectrally and spatially targeted illumination are disclosed. Intelligent lighting systems with programmable interfaces for customizing spectral and spatial light output to an individual user are also disclosed. Lighting fixtures including table and floor lamps with adjustable spectral output designed to coordinate with the time of day and human circadian rhythms are described. Adjustable light distribution units that provide for both indirect lighting and task lighting that may be independently varied with respect to color so as to illuminate and facilitate circadian rhythm regulation are also disclosed. 1. A lighting device operable to deliver specific spectral and spatial illumination comprising:a base;a light distribution unit secured to and above said base wherein the light distribution unit is operable to guide, reflect or transmit light;a first illumination source comprising an LED of a first color affixed or proximate to a lower portion of said light distribution unit and wherein said LED of the first color is oriented to emit light in a generally upward direction away from said base;a second illumination source comprising an LED of a second color affixed or proximate to an upper portion of said light distribution unit and wherein the LED of the second color is oriented to emit light in a generally a downward direction toward said base; andan electrical power driver for driving said LEDs to illumination wherein when both LEDS are powered to illumination the resulting illumination in the upward direction away from said base comprises predominantly light of said first color and the resulting illumination in the downward direction toward said base comprises predominantly light of said second color.2. The lighting device of wherein said LED of the first color is rich in melanopic light and said LED of the second color is depleted in melanopic light.3. The lighting device of wherein said LED of the first ...

Flashing Light Therapy with Image Presentation and Interaction for Treatment of Alzheimer's Disease and Dementia

The flashing light and cognitive therapy or video display presented on a mobile device or another screen used together to treat Alzheimer's disease and improve the brain's function. 1. A method of treatment of Alzheimer's disease in a human user , comprising:every t seconds showing on at least a portion of a screen a fixed or changing lighter image or color for x % of the t seconds and a fixed or changing darker image or color for y % of the t seconds, wherein the lighter image is on average more bright than the darker image or color;wherein t is 1/f;wherein f is between 30 Hz and 50 Hz;wherein x is greater than 0% and less than 100%; andwherein y is greater than 0% and less than 100%.2. The method of claim 1 ,wherein f is 40 Hz;wherein x is 33%; andwherein y is 66%.3. The method of claim 1 ,wherein f is 40 Hz;wherein x is 66%; andwherein y is 33%.4. The method of claim 1 ,wherein f is 40 Hz;wherein x is 50%; andwherein y is 50%.5. The method of claim 1 , wherein the screen is a TV screen.6. The method of claim 1 , wherein the screen is connected to or is a part of a computer device.7. The method of claim 6 , wherein the computer device is capable of receiving the user's input.8. The method of claim 1 , wherein the at least a portion of the screen is the entire screen.9. The method of claim 1 , wherein the lighter image or the darker image allows user to engage in cognitive training or in cognitive activity.10. The method of claim 1 , wherein the lighter image or the darker image is at least one of: a puzzle claim 1 , a Sudoku puzzle claim 1 , a memory game claim 1 , a crossword puzzle claim 1 , an action game claim 1 , a spatial orientation game claim 1 , a text claim 1 , or a video.11. A method of treatment of Alzheimer's disease in a human user claim 1 , comprising:every t seconds showing on a first at least a portion of a first screen a lighter image or color for x % of the t seconds and a darker image or color for y % of the t seconds; andshowing an image ...

Methods and compositions for treating alzheimer's disease and other memory-associated disorders and conditions

The invention, in part, relates to the use of optogenetic methods to increase dendritic spine density on DG memory engram cells in treatment methods for memory-impairment-associated diseases and conditions.

Apparatus and Methods for Reducing Frequency or Severity of Photophobic Responses or Modulating Circadian Cycles

The present disclosure describes systems, methods, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles by controlling light exposure to melanopsin ganglion cells in a retina over the action potential spectrum of the melanopsin cells of the human eye and a visual spectral response of the human eye. Embodiments of an optical filter are described. In one embodiment an optical filter may be configured to transmit less than a first amount of light weighted across the action potential spectrum of the melanopsin cells and to transmit more than a second amount of light weighted across the visual spectral response. Methods of manufacturing optical filters are also described.

DISPLAY APPARATUS AND DISPLAY SYSTEM

A display apparatus includes a display; an image processor which generates a first image including sequential first frame data and a second image including sequential second frame data; an image data generator which generates image data comprising the first frame data and the second frame data alternately; and a control signal generator which generates a shutter glasses control signal that opens shutters for both eyes of a first pair of shutter glasses when the first frame data is displayed on the display, and that closes the shutters for both eyes of the first pair of shutter glasses when the image data including the second frame data is displayed on the display. 1. A display apparatus comprising:a display;an image processor configured to generate a first image comprising sequential first frame data and a second image comprising sequential second frame data;an image data generator configured to generate image data which comprises the first frame data and the second frame data alternately; anda control signal generator configured to generate a shutter glasses control signal that opens shutters for both eyes of a first pair of shutter glasses when the first frame data is displayed on the display, and that closes the shutters for both eyes of the first pair of shutter glasses when the second frame data is displayed on the display.2. The display apparatus of claim 1 , further comprisinga receiver configured to receive image content,wherein the image processor generates the first image using the image content.3. The display apparatus of claim 2 , whereinthe image processor generates a third image comprising sequential third frame data based on the image content, andthe third image is an image for a person with a color vision deficiency, with at least one of red, green and blue emphasized more than the rest of the colors.4. The display apparatus of claim 3 , wherein the image data generator generates the image data comprising the first through third frame data ...

VIRTUAL REALITY HEADSET AND SYSTEM FOR DELIVERING AN INDIVIDUALIZED THERAPY SESSION

An individualized therapy session can be delivered to a patient using a virtual reality headset and system. In one example, the system can include an accelerometer and a processor. The processor can receive data detected by the accelerometer. The data can include head position data and head movement data. The processor can then determine a view direction of a user of the VR device using the head position data, determine a heart rate of the user by using the view direction of the user to process the head movement data, and output the heart rate of the user to a remote device. The processor can receive, from the remote device, a command to adjust a VR session presented by the VR device to the user. Based on the command, the processor can adjust one or more parameters of the VR session presented by the VR device. 1. A virtual reality (VR) device comprising:an accelerometer;a processor; and receiving data detected by the accelerometer, the data including head position data and head movement data;', 'determining a view direction of a user of the VR device using the head position data;', 'determining a heart rate of the user by using the view direction of the user to process the head movement data;', 'outputting the heart rate of the user to a remote device;', 'receiving, from the remote device, a command to adjust a VR session presented by the VR device to the user; and', 'adjusting, based on the command, one or more parameters of the VR session presented by the VR device., 'a memory including instructions that are executable by the processor for causing the processor to perform operations including2. The VR device of claim 1 , wherein the memory further includes instructions that are executable by the processor for causing the processor to determine the heart rate of the user by performing a Fourier transform on the head movement data.3. The VR device of claim 1 , wherein the VR session corresponds to a mental health treatment.4. The VR device of claim 1 , wherein the ...

LIGHTING SYSTEM

A system for influencing a being's perceived taste. The system comprises one or more input devices arranged to receive an input, the input corresponding to a desired of affected change in taste. For example the input may comprise a measure of one or more environmental factors taken using one or more sensors in a target environment, where the one or more environmental factors produce a perceived change in the being's taste. Alternatively the input may be indicative of a change specified for a certain product, user or place. The system further comprises one or more lighting devices arranged to output light into the target environment; and a controller configured to control the light output based on the input, in order to produce an influence on the being's perceived taste which at least partially compensates for the perceived change or goes towards producing the specified change. 1. A system for influencing a being's perception of taste of a product during consumption , the system comprising:one or more input devices arranged to receive an input, the input corresponding to a desired change in taste of the product during consumption;one or more lighting devices arranged to provide a light output in a target environment; anda controller configured to control the light output, in dependence on said input, to influence the being's perception of taste of the product during consumption in said target environment to achieve said desired change in taste,wherein said input further comprises an identification of a user, a location and/or product and wherein the controller is configured to control the light output further based on the identification.2. The system of claim 1 , wherein the one or more input devices comprise one or more sensors arranged to take a measurement of one or more environmental variables from the target environment claim 1 , the one or more environmental variables causing a perceived change in the being's taste; andthe controller is configured to control ...

METHODS FOR INDUCING NEUROGENESIS

A method for inducing neurogenesis in the brain of a mammal includes administering a light treatment from an LED light source. 1. A method for inducing neurogenesis in the brain of a mammal comprising administering to the mammal a light treatment from an LED light source , wherein the treatment induces neurogenesis.2. The method of claim 1 , wherein administering includes operating a device to emit light toward and shining into the mammal's eyes.3. The method of claim 1 , wherein the light treatment includes administering white light from the LED light source.4. The method of claim 1 , wherein administering the light treatment comprises light with a maximum peak in the 400 nm to 600 nm range of the light spectrum.5. The method of claim 1 , wherein administering the light treatment comprises light with a maximum peak between about 420 nm and 505 nm.6. The method of claim 1 , wherein administering the light treatment comprises light with at least 25% of the wavelengths 446 nm to 477 nm.7. The method of claim 1 , wherein the LED light source emits white light.8. The method of claim 1 , wherein administering the light treatment comprises light at an intensity of between 500 and 12 claim 1 ,000 lux at 12 inches.9. The method of claim 1 , said method further comprising exercise.10. The method of claim 1 , wherein the LED light source is a device comprising (i) an outer housing claim 1 , and (ii) a light emitting assembly in the housing and operable to emit light from the device claim 1 , the light emitting assembly including a plurality of LEDs capable of generating an output of light of between 500 and 12 claim 1 ,000 lux at 12 inches.11. A method of treating a neurodegenerative condition in a mammal claim 1 , comprising administering to the mammal a light treatment from an LED light source claim 1 , wherein the light treatment treats the neurodegenerative condition.12. The method of claim 1 , wherein the neurogenesis occurs in the hippocampal region of the brain.13. The ...

SYSTEM AND METHODS FOR OPERATING A LIGHTING DEVICE

A lighting device may include a light source, a control circuit, and a communication device positioned in communication with the control circuit. The communication device may be configured to receive a transmission from a user device, and the transmission may include a data structure. The data structure may include a show packet and an event packet. The show packet may include an ID string and information regarding a number of event packets associated with the data structure, and the event packet may include information regarding a lighting spectrum, a fade type, a fade duration, and a hold duration. The control circuit may be configured to operate the light source to emit light transitioning from a present light emission having a present spectral power distribution to a light emission having spectral power distribution indicated by the lighting spectrum according to the fade type and fade duration. 1. A lighting device comprising:a light source comprising a plurality of light-emitting diodes (LEDs);a control circuit configured to control the operation of the light source; anda communication device positioned in communication with the control circuit;wherein the communication device is configured to receive a transmission;wherein the transmission comprises a data structure;wherein the data structure comprises an event packet;wherein the event packet comprises information regarding a lighting spectrum, a fade type, and a fade duration; andwherein the control circuit is configured to operate the light source to emit light transitioning from a present light emission having a present spectral power distribution to a light emission having spectral power distribution indicated by the lighting spectrum according to the fade type and fade duration, and to operate the light source to emit light having the spectral power distribution indicated by the lighting spectrum.2. The lighting device of wherein the control circuit is configured to operate the light source so as to ...